Rakyat Amerika menuntut bayaran balik daripada tarif bernilai $180 bilion yang telah mereka bayar, dan mereka menyaman syarikat seperti Costco untuk merealisasikannya berita

Rakyat Amerika menuntut bayaran balik daripada tarif bernilai $180 bilion yang telah mereka bayar, dan mereka menyaman syarikat seperti Costco untuk merealisasikannya

March 13, 2026
(SeaPRwire) - Rakyat Amerika telah menanggung beban tarif Presiden Donald Trump, dan kini mereka menuntut bayaran balik. Keputusan Mahkamah Agung yang membatalkan tarif yang dikenakan di bawah Akta Kuasa Ekonomi Kecemasan Antarabangsa (IEEPA) membuka ruang bagi syarikat-syarikat A.S. untuk mendapatkan bayaran balik daripada kira-kira $180 bilion hasil cukai import. Kini, pelanggan yang mengalami kenaikan harga akibat tarif tersebut menuntut bahagian mereka yang adil. Data yang menyeluruh, termasuk laporan daripada Federal Reserve Bank of New York, menunjukkan bahawa pengimport A.S. menanggung sebahagian besar tarif tersebut—sehingga 90%—dengan ramai yang memindahkan peningkatan kos tersebut kepada pengguna Amerika. Goldman Sachs menganggarkan tarif tersebut menambah kenaikan 0.7% kepada inflasi dalam tempoh 10 bulan, dengan harga dijangka meningkat lagi 0.1% pada tahun 2026 disebabkan oleh levi tersebut. Sesetengah pengguna A.S. telah mengambil tindakan sendiri untuk mendapatkan semula kos tambahan yang mereka bayar bagi barangan yang dikenakan tarif sepanjang tahun lalu, termasuk meneruskan tindakan undang-undang terhadap syarikat-syarikat A.S. dengan menyaman untuk mendapatkan bayaran balik tarif. Pada hari Rabu, plaintif Matthew Stockov, seorang penduduk Illinois, memfailkan saman terhadap Costco, mendakwa peruncit besar itu menaikkan harga akibat tarif dan akan menerima "pemulihan berganda" jika ia mengutip bayaran balik cukai import tanpa mengagihkannya semula kepada pengguna. Aduan yang difailkan di Mahkamah Daerah A.S. bagi Daerah Utara Illinois itu menyatakan bahawa Stockov membeli barangan elektronik, makanan, perkakas, barangan rumah, dan produk kebersihan pada harga yang melambung tinggi akibat tarif. “Costco mampu mengembangkan margin semasa kemuncak rejim tarif IEEPA dengan menaikkan harga secara terpilih ke atas barangan yang dikenakan tarif,” menurut aduan tersebut. “Harga lebih tinggi yang dibayar oleh pengguna adalah akibat daripada peningkatan kos import Costco. Tanpa pengenaan tarif IEEPA yang menyalahi undang-undang, Costco tidak perlu menaikkan harga kepada pengguna dengan cara ini.” Menurut tuntutan mahkamah tersebut, cadangan kumpulan (class action) itu boleh merangkumi lebih daripada 100 pelanggan Costco yang didakwa berhak mendapat lebih $5 juta dalam bentuk bayaran balik tarif. Perjuangan pengguna untuk bayaran balik tarif Pada Mei 2025, CFO Costco, Gary Millerchip, memberitahu pelabur bahawa peruncit itu menaikkan harga bagi beberapa produk budi bicara seperti bunga akibat levi tersebut, tetapi mengekalkan harga bagi beberapa barangan hasil tani yang dikenakan tarif seperti pisang yang merupakan barangan keperluan bagi pembeli. Aduan tersebut merujuk kepada laporan terdahulu yang memetik unjuran Goldman Sachs dari Ogos 2025 yang menunjukkan pengguna telah menyerap 22% daripada jumlah kos tarif, tetapi diunjurkan menanggung 67% daripada kos tersebut menjelang Oktober 2025 apabila lebih banyak kos dipindahkan kepada pengguna. Costco tidak menjawab permintaan untuk komen, tetapi telah menyatakan rancangan untuk memberikan bayaran balik tarif kepada pelanggan. Peruncit itu adalah antara syarikat pertama yang menyaman pentadbiran Trump sebelum keputusan Mahkamah Agung pada bulan Februari dengan matlamat untuk memastikan pengagihan tarif dan mengelakkan ketidakpastian masa depan mengenai kelayakan bayaran balik. Dalam pembentangan pendapatan awal bulan ini, CEO Ron Vachris berkata syarikat itu akan memulangkan bayaran tarif yang diperoleh semula kepada pembeli melalui harga yang lebih rendah, walaupun hakikatnya "kesan masa depan tarif masih sangat tidak menentu." Bukan sahaja Costco yang mahu dipertanggungjawabkan oleh pembeli untuk mengagihkan bayaran balik. Bulan lalu, seorang pengguna turut menyaman EssilorLuxottica, pembuat cermin mata hitam Ray-Ban, mendakwa beliau berhak mendapat bayaran balik tarif kerana harga satu model cermin mata hitam meningkat daripada $287 pada Mac 2025 kepada $304 pada Mei. Plaintif membeli cermin matanya pada bulan Ogos. Pelanggan FedEx, Matthew Resier di Miami, juga memfailkan cadangan tindakan kumpulan terhadap syarikat penghantaran itu, mendakwa FedEx bertindak sebagai "ejen kastam," mengutip $36 dalam cukai import dan yuran ke atas sepasang kasut Jerman yang dihantar kepadanya. FedEx adalah salah satu daripada ribuan syarikat pertama yang menyaman pentadbiran Trump berikutan keputusan Mahkamah Agung. FedEx memohon perintah mahkamah yang akan memaksa Customs and Border Protection membayar balik jumlah penuh yang dibayar dalam tarif, yang dianggarkan oleh eksekutif sebelum ini hampir $1 bilion. Syarikat itu berkata ia merancang untuk memulangkan caj tarif kepada pelanggan jika kerajaan mengeluarkan bayaran balik. “Hasrat kami adalah jelas: jika bayaran balik dikeluarkan kepada FedEx, kami akan mengeluarkan bayaran balik kepada pengirim dan pengguna yang pada asalnya menanggung caj tersebut,” kata jurucakap kepada dalam satu kenyataan. “Bilakah itu akan berlaku dan proses tepat untuk meminta serta mengeluarkan bayaran balik akan bergantung sebahagiannya pada panduan masa depan daripada kerajaan dan mahkamah.” EssilorLuxottica tidak menjawab permintaan untuk komen. Adakah pengguna Amerika akan mendapat bayaran balik tarif sama sekali? Syarikat lain telah menyatakan dengan jelas niat untuk memberikan bayaran balik kepada pelanggan. Cards Against Humanity—pembuat permainan yang mengeluarkan produknya terutamanya di China—berkata berikutan keputusan itu, ia akan memindahkan caj tarif yang diperoleh semula kembali kepada pelanggannya, meminta mereka mengisi borang dalam talian dengan bukti pembayaran semasa tempoh tarif. “Apabila Pentadbiran Trump memberikan kami bayaran balik tarif kami, kami tidak akan menyimpannya,” kata syarikat itu dalam satu hantaran dalam talian. “Kami akan memberikan 100% wang itu kembali kepada anda, pelanggan setia kami, yang sebenarnya menjadikan perniagaan kami mungkin.” Dame Products, sebuah syarikat kesihatan dan kesejahteraan seksual yang mengutip $70,000 dalam surcaj tarif daripada pelanggan tahun lalu, merancang untuk memulangkan jumlah tersebut kepada pengguna, menurut CEO Alexandra Fine. Walau bagaimanapun, butiran mengenai bagaimana dan bila kerajaan akan mengagihkan bayaran balik tersebut masih tidak jelas. Mahkamah Agung tidak memberikan sebarang butiran mengenai bayaran balik dalam keputusannya, menyerahkan kepada mahkamah perdagangan yang lebih rendah untuk menentukan proses bagi mendapatkan semula caj tersebut. Hakim Richard Eaton dari Mahkamah Perdagangan Antarabangsa A.S. memutuskan minggu lalu bahawa pengimport memang berhak mendapat bayaran balik tarif. Trump sebelum ini menyatakan beliau akan melawan bayaran balik tersebut, dengan mahkamah berpotensi mengambil masa bertahun-tahun untuk membicarakan kes tersebut. Pakar rantaian bekalan berkata ia mungkin mengambil masa 12 hingga 18 bulan. Sementara itu, hasil tarif yang berada dalam Perbendaharaan A.S. sedang mengumpul faedah akibat peraturan persekutuan. Menurut laporan Cato Institute bulan ini, bayaran balik tersebut mengumpul $700 juta dalam bentuk faedah setiap bulan, yang juga akan dipindahkan kepada 130 juta isi rumah pembayar cukai Amerika. Cards Against Humanity mengakui ketidakpastian mengenai garis masa bayaran balik: “Malangnya, walaupun Tuhan sendiri tidak tahu berapa lama masa yang akan diambil.”Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Negara Amerika Latin beri amaran kepada Trump agar tidak membina empayar kewangan

Negara Amerika Latin beri amaran kepada Trump agar tidak membina empayar

March 13, 2026
(SeaPRwire) - Kenyataan oleh Presiden Colombia Gustavo Petro itu dibuat selepas Washington menculik pemimpin Venezuela dan mengancam Cuba Presiden Colombia Gustavo Petro telah memberi amaran kepada pentadbiran AS supaya tidak cuba membina “sebuah empayar” di Amerika Latin, sambil menggesa Washington untuk meneruskan dialog dan bukannya campur tangan ketenteraan. Kenyataan Petro itu dibuat selepas AS campur tangan di Venezuela pada bulan Januari, apabila tentera AS menahan Presiden Nicolas Maduro dalam satu serbuan di Caracas, dan di tengah-tengah amaran berulang daripada Washington mengenai kemungkinan “perubahan rejim” di Cuba. Amerika Latin bukanlah “tanah untuk ditakluki,” kata presiden Colombia itu dalam satu temu bual dengan Politico yang diterbitkan pada hari Khamis. “Saya percaya bahawa terdapat orang dalam kerajaan AS yang berfikiran sama: bahawa daripada memaksakan empayar yang sentiasa dibebaskan oleh rakyat Cuba, apa yang akhirnya diperlukan adalah untuk mewujudkan dialog antara benua Amerika dan memasukkan Cuba ke dalam dunia gentian optik dan tenaga bersih,” kata Petro. Ketua negara itu juga melontarkan kritikan terhadap Setiausaha Negara AS Marco Rubio dan bekas penasihat Trump serta jutawan Elon Musk. Beliau menuduh kedua-duanya mempromosikan visi “tamadun Barat yang berkulit putih dan beragama Kristian” dan memberi amaran agar tidak cuba menghidupkan semula “zaman Perang Salib,” sambil menyatakan bahawa retorik sedemikian boleh mencetuskan “tahap keganasan yang sangat besar dalam setiap masyarakat.” Selain Venezuela, Washington telah meluaskan operasi ketenteraan di rantau itu di bawah panji memerangi kartel dadah. Tentera AS telah menjalankan operasi di Ecuador dan mengancam tindakan serupa di Mexico, di samping melancarkan banyak serangan ke atas kapal-kapal yang disyaki terlibat dalam penyeludupan narkotik di Laut Caribbean dan timur Lautan Pasifik. Walaupun terdapat ketegangan, Bogota terus menyelaraskan usaha anti-narkotik dengan Washington. Awal tahun ini, Kementerian Dalam Negeri Colombia menyatakan bahawa kedua-dua negara telah bersetuju untuk mengambil “tindakan bersama” terhadap kumpulan gerila penyeludup kokain yang beroperasi di sepanjang sempadan dengan Venezuela. Kementerian Luar Negeri Rusia menyatakan bahawa laporan mengenai peningkatan tekanan AS terhadap Cuba adalah “sangat membimbangkan,” terutamanya selepas penahanan Maduro. Kementerian itu menyatakan bahawa tindakan sedemikian mewakili pelanggaran kedaulatan negara yang tidak boleh diterima. Timbalan menteri luar Rusia, Sergey Ryabkov, berkata penangkapan Maduro adalah “pelanggaran undang-undang antarabangsa yang nyata” dan mengulangi gesaan Moscow untuk pembebasannya.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
Peraturan EU Mengenai Dokumen Pengenalan Diri Warga Transgender kewangan

Peraturan EU Mengenai Dokumen Pengenalan Diri Warga Transgender

March 13, 2026
(SeaPRwire) - Dokumen pengenalan hendaklah mencerminkan "jantina yang dihayati" seseorang dan bukannya jantina biologi mereka, Mahkamah Kehakiman Eropah telah memutuskan Negara anggota EU diwajibkan untuk mengemaskini data jantina dalam dokumen pengenalan warganegara yang telah menjalani pertukaran jantina, Mahkamah Kehakiman Kesatuan Eropah (CJEU) telah memutuskan. Dokumen orang transgender di blok itu mesti mencerminkan "jantina yang dihayati" dan bukannya jantina biologi mereka, badan yang berpangkalan di Luxembourg itu berkata pada Khamis. CJEU sedang membuat keputusan mengenai kes 2017 yang dirujuk kepadanya oleh Mahkamah Kasasi Tertinggi Bulgaria. Ia ingin menjelaskan sama ada negara itu dikehendaki membuat perubahan pada sijil kelahiran seorang lelaki Bulgaria yang telah memulakan terapi hormon untuk mula hidup sebagai wanita selepas berpindah ke Itali. Pihak berkuasa di Sofia sebelum ini telah menolak permintaan itu, dengan memetik hakikat bahawa undang-undang Bulgaria menafsirkan 'jantina' secara ketat dari segi biologi. Hakim CJEU membuat kesimpulan bahawa keengganan negara untuk mengemaskini dokumen pengenalan warganegara transgender selepas mereka menggunakan hak mereka untuk tinggal di negara EU lain boleh menghalang kebebasan pergerakan dan melanggar hak kehidupan peribadi. Piagam Hak Asas blok itu "melindungi identiti jantina dan mewajibkan Negara Anggota menyediakan prosedur yang jelas, mudah diakses dan berkesan untuk pengiktirafan undang-undangnya," bacaan keputusan itu. "Perundangan negara anggota yang tidak membenarkan pengemaskinian data jantina salah seorang warganegaranya yang telah menggunakan haknya untuk kebebasan pergerakan adalah bertentangan dengan undang-undang EU," ia menekankan. Keputusan itu dialu-alukan oleh aktivis LGBTQ, dengan peguam Denitsa Lyubenova, yang mengetuai Deystvie Association, berkata bahawa ia "membuka pintu kepada komuniti kami untuk memetik secara tepat penghakiman ini dan mengambil manfaat daripada undang-undang EU serta dapat melakukan perjalanan secara bebas di seluruh EU." Kumpulan advokasi ILGA-Europe telah meminta Suruhanjaya Eropah untuk menggunakan penghakiman ini untuk bertindak terhadap Hungary dan Slovakia, yang juga hanya mengiktiraf dua jantina – lelaki dan perempuan. Rusia, yang telah mengambil langkah untuk mempromosikan nilai-nilai tradisional, telah melarang "peralihan jantina" dari segi undang-undang dan perubatan kecuali dalam kes perubatan yang serius pada tahun 2023. Tahun lepas, Moscow juga mengharamkan pengangkatan anak oleh mereka yang tinggal di negara yang membenarkan prosedur penukaran jantina. Menurut Presiden Rusia Vladimir Putin, Barat terlibat dalam apa yang beliau panggil "keganasan jantina."Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities ACN Newswire

General MRO Aerospace Achieves CAAC Certification, Expanding Global Maintenance Capabilities

March 13, 2026
MIAMI, FL, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - General MRO Aerospace (GMA) today announced that it has officially received certification from the Civil Aviation Administration of China (CAAC), authorizing the company to perform maintenance, repair, and overhaul (MRO) services for components on Chinese-registered aircraft.The certification marks a significant milestone in General MRO Aerospace's international growth strategy and further validates the company's commitment to the highest standards of safety, quality, and regulatory compliance."Achieving CAAC certification is an important step forward for General MRO Aerospace as we continue to expand our global footprint," said Jonathan Cornell, President of General MRO Aerospace. "This approval demonstrates the strength of our quality systems, our technical expertise, and our commitment to supporting Airline and MRO partners worldwide."The CAAC approval allows GMA to provide repair and overhaul services for a range of aircraft components in accordance with Chinese aviation regulatory requirements. The certification process included a comprehensive audit of the company's facilities, quality management system, technical procedures, and regulatory compliance programs.General MRO Aerospace already operates under FAA Part 145, EASA, CAA, and CAAT quality standards, and the addition of CAAC certification enables the company to better serve operators, lessors, and maintenance providers across the Asia-Pacific aviation market."With increasing global demand for high-quality component repair services, this certification strengthens our ability to support customers operating in China and throughout the region," Cornell added. "We look forward to building strong partnerships with Chinese airlines and aviation organizations."General MRO Aerospace specializes in the repair and overhaul of complex aircraft components, supporting commercial and cargo operators worldwide with reliable turnaround times, technical excellence, and customer-focused service.About General MRO AerospaceGeneral MRO Aerospace is an AS9110 and ISO 9001 accredited U.S.-based aviation maintenance, repair, and overhaul provider specializing in component repair and support services for commercial aircraft operators worldwide. Operating under FAA Part 145, EASA, CAA, CAAT, and CAAC certification, the company delivers high-quality technical solutions, responsive customer service, and dependable turnaround times to airlines, leasing companies, and MRO partners around the globe.Media ContactMichelle TorresMarketing SpecialistGeneral MRO AerospaceMtorres@GeneralMROAerospace.comwww.GeneralMROAerospace.comSOURCE: General MRO Aerospace Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Lebih ramai orang akan memiliki robot humanoid daripada kereta menjelang 2060, ramal BofA

March 13, 2026
(SeaPRwire) - Revolusi robot tidak akan didorong oleh fiksyen sains, menurut Bank of America. Ia akan didorong oleh demografi. Dalam nota penyelidikan terperinci, BofA Global Research meramalkan bahawa populasi robot humanoid global akan mencapai 3 bilion unit menjelang 2060—melebihi kira-kira 1.5 bilion kereta di dunia dari segi per kapita. Menjelang ketika itu, bank itu menganggarkan 62% daripada semua robot humanoid, atau kira-kira 2 bilion unit, akan digunakan di dalam rumah orang ramai. Ia adalah angka yang menakjubkan untuk kategori produk yang pada asalnya mempunyai penembusan pasaran sifar hari ini, tetapi BofA menunjukkan kepada fakta ekonomi yang tidak dapat dinafikan dalam kehidupan abad ke-21 sebagai motif utama: tidak akan ada pekerja yang mencukupi. Masalah tenaga kerja yang dicipta robot untuk selesaikan Revolusi robot tidak akan didorong oleh perkara baru. Ia akan didorong oleh keperluan. Penganalisis BofA Lynelle Huskey dan Vanessa Cook mengenal pasti tenaga kerja yang semakin tua, kekurangan tenaga kerja yang berterusan, inflasi gaji, dan kadar peralihan pekerja yang tinggi sebagai daya struktur yang menjadikan tenaga kerja humanoid menarik dari segi ekonomi—dan mereka menekankan bahawa ini akan berlaku walaupun sebelum humanoid sepenuhnya menyamai keupayaan manusia. Anda tidak memerlukan robot yang sempurna. Anda memerlukan robot yang muncul, tidak berhenti kerja, dan kosnya lebih rendah daripada pekerja yang anda tidak dapat cari. Tekanan itu adalah global. Di Jepun, Jerman, dan Korea Selatan, populasi usia bekerja yang mengecil telah menekan pembuatan dan perkhidmatan selama bertahun-tahun. Di Amerika Syarikat, pertumbuhan gaji dalam logistik, storan, dan penjagaan warga tua telah melebihi inflasi yang lebih luas. Di Humanoids Summit pada Disember 2025, lebih daripada 2,000 eksekutif, jurutera, dan pelabur berkumpul untuk mencapai pandangan konsensus yang terang: “Soalannya sebenarnya hanyalah berapa lama ia akan mengambil masa.” BofA kini meletakkan nombor pada garis masa itu. Dari kilang ke ruang tamu Sebelum humanoid sampai ke ruang tamu, mereka akan menghabiskan tahun-tahun di dock memuat dan barisan pemasangan. Data Counterpoint Research yang dipetik dalam laporan BofA meramalkan bahawa menjelang 2027, 72% daripada semua pemasangan humanoid akan tertumpu dalam storan dan logistik (33%), automotif (24%), dan pembuatan (15%). Aplikasi runcit dan perkhidmatan hanya menyumbang 12%. Humanoid rumah adalah cerita tahun 2040-an. Robot yang mengeluarkan barang dari trak anda adalah cerita tahun 2027. Corak “perindustrian terlebih dahulu” itu sudah boleh dilihat dalam perjanjian yang dibuat. UPS sedang dalam perbincangan aktif dengan Figure AI untuk menggunakan humanoid di seluruh rangkaian logistiknya. Optimus Tesla sedang mencatatkan jam kerja berbayar di dalam Gigafactory Tesla sendiri, dengan Musk menyasarkan jualan awam menjelang akhir 2027—walaupun dia telah memberi amaran bahawa pelancaran akan “sangat perlahan.” CEO Arm Rene Haas berkata di Brainstorm AI pada Disember meramalkan AI fizikal akan mengautomatiskan “bahagian besar” kerja kilang dalam lima hingga sepuluh tahun, dengan humanoid tujuan am dapat menukar tugas secara serta-merta dengan cara yang tidak dapat dilakukan oleh mesin industri warisan. $4.3 bilion dan semakin pantas Pelaburan menceritakan kisah sektor yang telah decisif menyeberangi dari penyelidikan ke perlumbaan. BofA menganggarkan bahawa pendanaan untuk robotik humanoid meningkat daripada $0.7 bilion pada 2018 kepada $4.3 bilion pada 2025—peningkatan enam kali ganda dalam tujuh tahun. Sejak Januari 2026, ia mendapati lebih daripada 50 syarikat secara aktif membina humanoid, dengan 150 pelancaran produk komersial sudah dicatatkan. BofA meramalkan penghantaran tahunan akan meningkat dari 90,000 unit pada 2026 kepada 1.2 juta menjelang 2030, yang membayangkan kadar pertumbuhan tahunan majemuk 86%—trajektori yang lebih curam daripada pasaran EV awal. Keluk kos adalah enjin di sebalik pertumbuhan itu. Humanoid buatan China mempunyai kos bahan-bahan sebanyak $35,000 pada 2025; BofA meramalkan ia akan turun ke bawah $17,000 menjelang 2030. Robot peringkat panduan buatan Barat pada masa ini kos $90,000–$100,000 setiap unit untuk dihasilkan, bermakna mampatan kos yang masih akan datang adalah sangat besar. Syarikat startup Norway 1X sudah menyewakan humanoid yang mampu digunakan di rumah dengan harga $499 sebulan, dan Unitree’s G1 dihantar dengan harga $13,500—nombor yang sudah memaksa pesaing Barat untuk mempercepatkan peta jalan kos mereka sendiri. Pendapat Skeptik Tidak Salah — Hanya Dilawan oleh Matematik Revolusi robot sudah tentu tidak tanpa pengkritik. Ahli robotik MIT dan pengasas bersama iRobot Rodney Brooks berkata pada September bahawa visi robot domestik Musk adalah “pemikiran fantasi tulen,” meramalkan bahawa robot yang berjaya akan mempunyai roda dan tidak akan kelihatan seperti manusia. Peter Cappelli dari Wharton memberi amaran dalam halaman majalah bulan lepas bahawa panik terhadap pergantian pekerjaan yang didorong oleh robot adalah pramatang. Sementara itu, penyelidik Silicon Valley masih lebih berhati-hati terhadap garis masa berbanding rakan sepasukan mereka di China, di mana mandat kerajaan dan skala pembuatan mendorong penggunaan yang lebih cepat. Kritikan tersebut tidak membatalkan ramalan 35 tahun. Tetapi mereka menekankan apa yang diakui oleh BofA sendiri: jalan dari robot kilang $35,000 hari ini ke dunia 3 bilion unit melintasi satu siri halangan teknologi, peraturan, dan ekonomi yang tidak dapat dimodelkan sepenuhnya oleh mana-mana ramalan. Apa yang dikatakan oleh bank itu—and what founders and experts on the ground confirm—is bahawa tekanan demografi adalah nyata, modal telah ditetapkan, dan keluk kos sudah bergerak. Peralihan dari kereta ke robot mungkin menjadi kisah teknologi pengguna yang menentukan pada tiga dekad akan datang. Bank of America hanyalah yang pertama meletakkan tarikh kepadanya. Untuk cerita ini, wartawan menggunakan AI generatif sebagai alat penyelidikan. Editor mengesahkan ketepatan maklumat sebelum diterbitkan.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China ACN Newswire

CMS (867.HK/8A8.SG) : New Drug for Renal Anaemia Desidustat Tablets Approved in China

March 13, 2026
SHENZHEN, CHINA, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (“CMS”, or the “Group”) is pleased to announce that on 13 March 2026, new drug for renal anaemia Desidustat Tablets (the “Product”) has been approved for marketing in China by the National Medical Products Administration of the People’s Republic of China (NMPA). The Product is a novel, oral HypoxiaInducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in non-dialysis adult, Chronic Kidney Disease (CKD) patients.The approval of Desidustat Tablets will further strengthen the Group’s overall layout in the field of nephrology, and synergize with the marketed innovative drug Velphoro (Sucroferric Oxyhydroxide Chewable Tablets, indicated for CKD hyperphosphatemia). Through the efficient linkage of nephrology expert resources and channel networks, the Group is expected to rapidly promote the large-scale clinical application of Desidustat Tablets, providing differentiated treatment options for Chinese CKD patients with renal anaemia and making a positive contribution to the Group’s performance.More information about Desidustat Tablets and Renal AnaemiaAs a novel oral HIF-PHI, the Product’s mechanism of action promotes erythropoiesis through increasing endogenous erythropoietin, improving iron availability and reducing hepcidin. Its China Phase III clinical trial has demonstrated positive results. The primary endpoint of the haemoglobin (Hb) mean change from baseline to Week 7-9 has indicated that, Desidustat is more effective than placebo in increasing Hb level. Results from the extension study demonstrate that the Product can maintain Hb level within the target range over the long term with acceptable safety. In addition, the Product significantly reduces hepcidin levels and ameliorates iron metabolism disorders.There is still a large unmet need in the treatment of anaemia in CKD patients in China. It is estimated that there are more than 120 million CKD patients in China[1]. Anaemia is one of the frequent complications of CKD, which exhibits a progressively increasing incidence with disease progression. A survey in China showed that the prevalences of anaemia in patients at CKD stage 1 to 5 were 22.0%, 37.0%, 45.4%, 85.1%, and 98.2%, respectively[2]. The target-achieving rate (the Hb level reaching the target value (110~120g / L)) has increased to 51.5% for haemodialysis CKD patients with anaemia[3], but is still only 8.2% for anaemia patients in non-dialysis CKD[4]. The Product is administrated orally, thus expecting to improve the treatment compliance of patients and to meet the unmet treatment needs in the field of CKD anaemia.Desidustat Tablets have been approved for marketing in India.CMS INTERNATIONAL DEVELOPMENT AND MANAGEMENT LIMITED, a wholly-owned subsidiary of the Group, obtained an exclusive license for the Product from Zydus Lifesciences Limited (earlier known as Cadila Healthcare Limited) pursuant to a License Agreement with an effective date of 20 January 2020.The Group adheres to its core strategy of “innovation-driven”, having established a tiered and multi-dimensional innovation product portfolio with abundant reserves: 7 new drugs have been approved for marketing, 6 are currently under marketing review, and nearly 20 projects are about to initiate or are progressing through clinical trials. Through a dual-engine innovation approach combining collaborative development and in-house R&D, the Group continuously enriches its innovative pipeline centered on first-in-class (FIC) and best-in-class (BIC) products, efficiently advancing clinical development and commercialization. Moving forward, CMS will remain clinical needs-driven to deliver more quality pharmaceutical solutions, steadfastly advancing toward the goal of becoming a specialty-focused, innovation-excellent multinational pharmaceutical enterprise.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference1. ZhangL, WangF, WangL, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. DOI: 10.1016/S0140-6736(12)60033-62. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2014 Revised Edition)[J]. Chinese Journal of Nephrology, 2014, 30(9): 712-716. DOI: 10.3760/cma.j.issn.1001-7097.2014.09.0153. 19th CSN Critical Care & Blood Purification Congress, Chinese Medical Association (July 2-5, 2025)4. Chinese Expert Consensus on the Diagnosis and Treatment of Renal Anemia (2018 Revised Edition)[J]. Chinese Journal of Nephrology, 2018, 34(11): 860-866. DOI: 10.3760/cma.j.issn.1001-7097.2018.11.012CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo SeaPRwire

CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo

March 13, 2026
SHENZHEN, CHINA, Mar 13, 2026 – (ACN Newswire via SeaPRwire.com) – On 12 March 2026, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health, which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) has its innovative prescription medicine ruxolitinib phosphate cream (Lumirix®) (the “Product”, marketed as Opzelura® in the U.S., Europe and Canada) recorded the initial prescriptions for vitiligo patients across 30 provincial-level regions. The prescriptions cover approximately a thousand influential public and private medical institutions in the field of skin health and disease management, including Huashan Hospital, Fudan University, Shanghai Skin Disease Hospital, Dermatology Hospital of Southern Medical University, Second People’s Hospital of Chengdu, The First Bethune Hospital of Jilin University, The Second Xiangya Hospital of Central South University, United Family Healthcare Group, among others*. Meanwhile, the Product has become concurrently accessible via over 1,300 offline drugstores as well as JD.com e-commerce platform. *Hospital rankings are listed in no particular order. As the first topical JAK inhibitor approved in China for the treatment of vitiligo, ruxolitinib phosphate cream has officially launched its large-scale clinical application today, marking a breakthrough in China’s vitiligo treatment landscape and ushering in a new era of precision targeted therapy for vitiligo. Supported by safety and efficacy fully demonstrated in clinical studies, the Product is expected to bring new hope for repigmentation to millions of vitiligo patients. The rapid commercialization progress of ruxolitinib phosphate cream underscores strong product operation capabilities of CMS (including Dermavon), while also reflecting the robust supports from China’s regulatory reforms in accelerating patient access to clinically urgently needed innovative drugs. Benefiting from the integrated healthcare ecosystem of the Hainan Free Trade Port and the “Urgently Needed Imported Drugs for Clinical Use” policy, the Product initiated pilot clinical use in August 2023 at Boao Super Hospital within the Boao Lecheng International Medical Tourism Pilot Zone. Pilot usage subsequently expanded to designated medical institutions across the Guangdong–Hong Kong–Macao Greater Bay Area, Beijing-Tianjin region and other regions. In accordance with the relevant regulations of China’s real-world data application pilot project, as well as supported by the Hainan Provincial Medical Products Administration and the Administration of the Boao Lecheng International Medical Tourism Pilot Zone, the Product has accumulated real-world clinical data in China under pilot application, significantly accelerating its clinical, registration and approval timelines. The Product received its Drug Registration Certificate on January 30, 2026 (approval date: January 27, 2026). Following its approval, in less than 1.5 months (including the Chinese New Year holiday), the initial prescriptions for ruxolitinib phosphate cream have been issued across multiple regions and hospitals, reflecting the highly efficient collaboration and concerted efforts among CMS teams, regulatory authorities and business partners. With robust support from the cross-departmental coordination mechanism of the Beijing Daxing Airport Economic Zone Joint Administrative Committee, once import conditions were met, the Product completed customs clearance approval, sampling and related customs procedures within 24 hours, and obtained the drug testing report within 7 working days, representing efficient execution and acceleration for the innovative drugs in China. During this process, the Beijing Municipal Medical Products Administration proactively provided end-to-end policy guidance; the government service center has efficiently completed customs clearance filing; the Beijing Institute for Drug Control has conducted methodological pre-testing to accelerate timelines for innovative drug, and continuous worked during the Chinese Spring Festival; and Daxing Airport Customs provided specialized pre-guidance on declaration and swiftly completed customs review and release. Through parallel workflows and coordinated execution, all parties collectively pressed the “fast-forward button” for the Product’s commercialization, helping this urgently needed innovative therapy reach patients faster. As the Product enters the large-scale clinical application stage, it is expected to further strengthen Dermavon’s comprehensive dermatology solutions and brand value. Building on its leadership in skin health, Dermavon will continue to improve accessibility of ruxolitinib phosphate cream to benefit more vitiligo patients and steadfastly safeguard public skin health through innovation. About Vitiligo Vitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. The discolored areas usually get bigger with time and the condition could influence skin on any part of the patients’ body. Vitiligo usually affects the appearance of patients, especially on exposed areas such as the face and neck. According to a study that involved over 1,000 diagnosed vitiligo patients, over 45% of patients have facial involvement, and over 20% of patients have neck involvement[1].The obvious presence of white patches may make patients feel that their appearance has been compromised, which in turn materially affects their social life, and is associated with a significantly higher incidence of mental health disorders; accordingly, there is an urgent need for effective treatment options for vitiligo[2]. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[1]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. Ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance. More Information About Ruxolitinib Phosphate Cream Ruxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is the first and only drug approved for the repigmentation of non-segmental vitiligo by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)[3,4]. In the U.S., the Product is indicated for the topical treatment of nonsegmental vitiligo in adult and pediatric patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis (AD) in non-immunocompromised adult and pediatric patients aged 2 years and older whose disease is not well controlled with topical prescription therapies, or when those therapies are not advisable. In Europe, ruxolitinib phosphate cream is approved for the topical treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age. In China, besides vitiligo indication, the product’s NDA for the treatment of mild-to-moderate AD in adults and pediatric patients aged 2 years and older is also under regulatory review, which has been included in the Priority Review List and is expected to accelerate the Product’s AD review process for marketing approval. The Group, through the subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside of Mainland China to the Group (excluding Dermavon and its subsidiary). Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream (excluding territories in which exclusive rights have already been licensed), marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group. Reference: 1. China Insights Consultancy’s industrial report 2. Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis[J]. Journal of the European Academy of Dermatology and Venereology, 2018,32(8):1343-1351. DOI:10.1111/jdv.14739. 3. The U.S. FDA approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream 4. The EMA approval information can be found on the Incyte official website, as follows: https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurar CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
More
Harga minyak terkini setakat 13 Mac 2026 berita

Harga minyak terkini setakat 13 Mac 2026

March 13, 2026
(SeaPRwire) - Pukul 8:30 pagi waktu Timur hari ini, harga minyak adalah $99.84 sebarrel dengan Brent sebagai penanda aras (kita akan menjelaskan penanda aras yang berbeza kemudian dalam artikel ini). Itu merupakan kenaikan sebanyak $1.08 berbanding pagi semalam dan kira-kira $29.47 lebih tinggi daripada harga setahun yang lalu. Harga minyak sebarrelPerubahan %Harga minyak semalam$98.76+1.09%Harga minyak 1 bulan yang lalu$67.92+46.99%Harga minyak 1 tahun yang lalu$70.37+41.87% Adakah harga minyak akan naik? Adalah mustahil untuk meramalkan harga minyak dengan ketepatan terperinci. Banyak elemen yang berbeza mempengaruhi pasaran, tetapi akhirnya ia bergantung kepada penawaran dan permintaan. Apabila kebimbangan mengenai kemelesetan ekonomi, perang, dan gangguan berskala besar yang lain meningkat, arah harga minyak boleh berubah dengan cepat. Bagaimana harga minyak berhubung dengan harga minyak di pompa Harga minyak di pompa tidak hanya mengikuti harga minyak mentah. Ia juga termasuk kos penapisan dan pengangkutan bahan api itu, cukai yang dikenakan, dan tambahan harga yang ditambahkan oleh stesen minyak tempatan anda untuk terus beroperasi. Oleh kerana minyak mentah biasanya membentuk sebahagian besar daripada kos segalon, perubahan dalam harganya mempunyai kesan yang besar. Apabila harga minyak melonjak, harga minyak biasanya naik seiring dengan itu. Tetapi apabila harga minyak turun, harga minyak di pompa seringkali ketinggalan dalam penurunan, satu trend yang kadang-kadang digambarkan sebagai “roket dan bulu”. Peranan Simpanan Minyak Strategik AS Pada masa kecemasan, AS mempunyai simpanan minyak mentah yang dikenali sebagai Simpanan Minyak Strategik. Tujuan utamanya adalah keselamatan tenaga sekiranya berlaku bencana (seperti sekatan, kerosakan akibat ribut hebat, malah perang). Tetapi ia juga boleh membantu mengurangkan kenaikan harga yang mencederakan semasa kejutan penawaran. Ia bukanlah penyelesaian jangka panjang dan lebih bertujuan untuk memberikan kelegaan sementara, membantu pengguna dan memastikan bahagian kritikal ekonomi berjalan, seperti industri utama, perkhidmatan kecemasan, pengangkutan awam, dan sebagainya. Bagaimana harga minyak dan gas asli berkait Kedua-dua minyak dan gas asli adalah sumber tenaga utama yang kita gunakan setiap hari. Oleh kerana itu, perubahan besar dalam harga minyak boleh mempengaruhi gas asli. Sebagai contoh, jika harga minyak meningkat, sesetengah industri mungkin menggunakan gas asli untuk beberapa bahagian operasi mereka jika boleh, yang meningkatkan permintaan untuk gas asli. Prestasi sejarah minyak Untuk mengukur prestasi minyak, kita sering melihat kepada dua penanda aras: Minyak mentah Brent, penanda aras minyak global utama. West Texas Intermediate (WTI), penanda aras utama Amerika Utara Antara kedua-duanya, Brent lebih mewakili prestasi minyak global kerana ia menentukan harga kebanyakan minyak mentah yang diperdagangkan di dunia. Dan, ia sering menjadi cara terbaik untuk mengesan prestasi sejarah minyak. Malah, Jabatan Maklumat Tenaga AS kini menggunakan Brent sebagai rujukan utama dalam Tinjauan Tenaga Tahunan mereka. Melihat penanda aras Brent selama beberapa dekad, harga minyak tidak pernah stabil. Ia mengalami lonjakan akibat faktor-faktor seperti perang dan pemotongan penawaran, dan ia juga mengalami kejatuhan akibat kemelesetan ekonomi global dan kelebihan penawaran (disebut “glut”). Sebagai contoh: Awal 1970-an membawa kejutan minyak besar pertama apabila Timur Tengah memotong eksport dan mengenakan embargo ke atas AS dan negara-negara lain semasa Perang Yom Kippur. Harga turun pada pertengahan 1980-an kerana sebab-sebab seperti permintaan yang lebih rendah dan lebih ramai pengeluar minyak bukan OPEC memasuki industri. Harga melonjak sekali lagi pada tahun 2008 dengan peningkatan permintaan global, tetapi ia segera jatuh bersama-sama dengan krisis kewangan global. Semasa pengurungan COVID 2020, permintaan minyak runtuh seperti tidak pernah sebelum ini—membawa harga ke bawah $20 sebarrel. Secara keseluruhannya, prestasi sejarah minyak tidak pernah lancar. Sekali lagi, ia sangat dipengaruhi oleh perang, kemelesetan ekonomi, kehendak OPEC, inisiatif dan dasar tenaga yang berkembang, dan banyak lagi. Liputan tenaga daripada Ingin kekal terkini mengenai perkembangan tenaga terkini? Lihat liputan terkini kami: Harga minyak dan baja sedang meningkat. Bil belanja makanan anda mungkin ikut Google dan Tesla tahu elektrik mahal. Mereka bekerjasama untuk memberi anda alternatif Exxon, Chevron, dan pengeluar dan penapis minyak dan gas AS yang lain mencapai nilai saham tertinggi sepanjang masa Soalan lazim Bagaimana harga minyak sebarrel semasa sebenarnya ditentukan? Harga minyak sebarrel semasa sebahagian besarnya bergantung kepada penawaran dan permintaan, termasuk berita mengenai potensi penawaran dan permintaan masa depan (geopolitik, keputusan yang dibuat oleh OPEC+, dll.). Di AS, harga juga berubah berdasarkan sejauh mana pentadbiran mesra terhadap penggerudian, kerana ia boleh mempengaruhi penawaran masa depan. Sebagai contoh, pada tahun 2025, pentadbiran Trump bergerak untuk membuka semula lebih daripada 1.5 juta ekar di Dataran Pantai Kawasan Perlindungan Hidupan Liar Kutub Utara untuk pajakan minyak dan gas, membatalkan dasar pentadbiran Biden yang mengehadkan penggerudian minyak di Kutub Utara. Seberapa kerap harga minyak berubah sepanjang hari? Harga minyak dikemas kini secara berterusan apabila pasaran “futures” terbuka. Pasaran futures sebenarnya adalah sebuah lelongan di mana orang bersetuju untuk membeli atau menjual minyak pada masa hadapan. Selagi orang dan syarikat berdagang kontrak, harga minyak akan berubah. Bagaimana pengeluaran minyak serpih AS mempengaruhi harga minyak semasa? Pendek kata, serpih adalah batu yang mengandungi minyak dan gas asli. Anggap serpih sebagai tenaga yang belum dimanfaatkan. Semakin banyak serpih yang diakses oleh AS, semakin banyak tenaga yang kita akan ada—dan semakin mudah harga minyak dapat dikawal agar tidak melonjak terlalu tinggi kerana penawaran yang lebih besar. Bagaimana harga minyak semasa memberi kesan kepada inflasi dan ekonomi secara lebih luas? Apabila minyak mahal, ia cenderung membuatkan barang-barang harian lebih mahal. Ini boleh berkaitan dengan tenaga (pemanasan anda, utiliti gas, dll.), tetapi ia juga disebabkan oleh logistik yang terlibat untuk membuatkan barang-barang itu mudah didapati oleh anda. Pengangkutan, sebagai contoh, boleh mempengaruhi harga barang di kedai runcit, kerana lebih mahal untuk membawa produk-produk itu dari gudang dan ladang ke rak.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
CITIC Resources Deepens Dual-Engine Strategy of ‘Investment + Trading’, Continues to Promote High-Quality Development ACN Newswire

CITIC Resources Deepens Dual-Engine Strategy of ‘Investment + Trading’, Continues to Promote High-Quality Development

March 13, 2026
HONG KONG, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) – CITIC Resources Holdings Limited (hereinafter referred to as CITIC Resources or the Company, or the Group when its subsidiaries are included; Stock Code: 1205.HK) has announced its annual results for the year ended 31 December 2025 (the “Year”). During the Year, the Group actively responded to the complex international environment and cyclical industry pressures. Systematically advancing initiatives in “upstream asset deployment, expansion of trading business, and enhancement of production and operations”, the Group deepened its dual-engine development model of “investment + trading”, stabilised its core operations, cultivated a second growth curve, and demonstrated robust operational and developmental resilience.As a key growth driver for the Group, the oil and gas trading business within the import and export segment expanded steadily during the Year, achieving a significant milestone with a trading volume exceeding 20.0 million barrels and revenue reaching approximately HK$11.34 billion. Meanwhile, the Group broke the long-standing monopoly of the sales channel of crude oil, enhancing the market value of its oil and gas properties. In the non-oil-and-gas business, the Group consistently prioritises refined and proactive management of its equity investments as a core task and actively conveyed its philosophy of improving quality and enhancing efficiency to the operators. Notably, the value of shares held in Aloca Corporation (“Aloca”) increased by approximately 46.3% during the Year. On the oil and gas front, focusing on refined reservoir management and continuous scientific research breakthroughs, the Group achieved stable production and increased reserves. It comprehensively deepened lean management throughout the production process, coupled with the implementation of cost-reduction and efficiency-enhancement measures, propelled continuous improvements in management standards and operational efficiency across all phases of oil and gas projects from exploration, development to production.During the Year, the Group achieved revenue of approximately HK$14.96 billion (2024: approximately HK$9.50 billion), representing a year-on-year increase of approximately 57.6%. Impacted by factors such as a decline in the average selling price of crude oil and coal, and higher raw material costs, profit attributable to ordinary shareholders of the Company amounted to approximately HK$0.17 billion (2024: HK$0.57 billion). Despite that, all of the Group’s segments recorded profits for the Year and the Group continued to maintain a strong financial position with cash and deposits of approximately HK$3.52 billion as at 31 December 2025 (31 December 2024: HK$2.03 billion). As at 31 December 2025, the Group had total assets of approximately HK$14.61 billion, and net assets attributable to ordinary shareholders of the Company of approximately HK$8.79 billion. The gearing ratio and interest-bearing debt ratio were approximately 38.8% and 23.5% respectively, with a return on equity (annualised) of approximately 2.0%.As part of its efforts to optimise its asset structure, the Group disposed of shares in Alcoa in January and March 2026, totalling approximately 2.17% of Alcoa’s total issued shares[1]. By seizing the opportunity to monetise its investment at a high valuation, the Group continues to create greater value for its shareholders.Mr. Hao Weibao, Executive Director, Chairman and Chief Executive Officer of CITIC Resources, said: “Looking ahead to 2026, the Group will focus on key areas such as the development, production and trading of oil and gas, as well as investments in the aluminum industry chain, deepen synergies among trading, investment and production management, and continue to implement the business strategy of consolidating the existing core business and pursuing dual-engine expansion through ‘investment + trading’.To consolidate our existing principal business, the Group will continue to enhance lean production and operational management to increase reserves and output, while steadily expanding production and sales scale. The Group will also intensify the introduction and application of new processes and technologies, leveraging technological innovation to empower high-quality development of our core businesses and reinforce our core growth foundation.On the dual-engine driver of ‘investment + trading’ expansion front, the Group will continue to track and position in high-quality oil and gas assets and the aluminium-centric key metals industry chain. Trading operations and investment projects will be deeply integrated: the investment arm will secure equity resources, while the trading arm will achieve market-oriented sales. This approach will also enhance our market sensitivity, enabling us to identify and acquire high-quality upstream resources and assets, thereby creating a virtuous cycle in which ‘investment acquires resources and trading converts value’. The Group is committed to implementing these development strategies and will continue to deliver long-term and stable returns to our shareholders.”[1]Details regarding the disposal were disclosed in the announcements and circular dated 16 January, 6 February, and 5 March.For details of CITIC Resources’ 2025 annual results, please refer to the Group’s annual results announcement on the Hong Kong Stock Exchange and the Group’s website.About CITIC Resources Holdings Limited (Stock Code: 1205.HK)CITIC Resources Holdings Limited has been listed on the Hong Kong Stock Exchange since 1997. Principal activities of CITIC Resources include the exploration, development and production of oil and coal, investments in bauxite mining, alumina refinery, aluminium smelting and oil and gas trading. CITIC Limited is the largest shareholder with about 59.5% interest in CITIC Resources. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Dua kanak-kanak terbunuh dalam serangan di pinggiran Tehran – perkhidmatan kecemasan kewangan

Dua kanak-kanak terbunuh dalam serangan di pinggiran Tehran – perkhidmatan kecemasan

March 13, 2026
(SeaPRwire) - Kematian ini mengikuti serangan ke atas sekolah rendah kanak-kanak perempuan di Minab, di mana lebih daripada 160 orang kehilangan nyawa mereka Serangan ke atas kawasan perumahan di pinggiran Qods, Tehran telah menyebabkan sekurang-kurangnya dua kanak-kanak terbunuh, kata pegawai tempatan. Serangan ke atas sekolah rendah kanak-kanak perempuan di Minab pada hari pertama perang AS-Israel terhadap Iran menyebabkan lebih daripada 160 orang kehilangan nyawa. Pembomban di Qods juga menyebabkan kira-kira 17 orang cedera, demikian kata kenyataan perkhidmatan kecemasan Wilayah Tehran pada Jumaat. Para cedera, sepuluh daripadanya adalah wanita, telah dihantar ke hospital dengan tergesa-gesa, tambahnya. Perkhidmatan kecemasan telah mengutuk serangan itu sebagai “tindakan tidak berperikemanusiaan” dan “jenayah terhadap orang awam,” tetapi tidak menyebut pihak yang bertanggungjawab. TV negara Iran melaporkan beberapa letupan di seluruh ibu kota pada Jumaat, menambah bahawa peluru berpandu juga menghantam tidak jauh dari kawasan di pusat bandar di mana sebuah perhimpunan pro-kerajaan besar telah diadakan. Para pegawai tinggi Iran, termasuk Setiausaha Majlis Keselamatan Negara Tertinggi Ali Larijani dan ketua Organisasi Tenaga Atom Mohammad Eslami, dilaporkan telah mengambil bahagian dalam demonstrasi pada Hari Quds, yang ditandakan pada Jumaat terakhir Ramadan, untuk menyokong perkara Palestin. Pada 28 Februari, sekurang-kurangnya 175 orang, hampir kesemuanya kanak-kanak, terbunuh dalam serangan ke atas sekolah kanak-kanak perempuan Shajarah Tayyebeh di bandar pesisir Minab di timur laut Iran. Tehran menuduh AS dan Israel melakukan “jenayah perang.” Seorang jurucakap tentera Israel menafikan sebarang penglibatan, manakala pegawai di Washington bersikeras bahawa tentera AS tidak menyasarkan orang awam. Presiden AS Donald Trump mendakwa bahawa sekolah itu telah dihantam oleh Iran sendiri “kerana mereka sangat tidak tepat… dengan peluru mereka.” Walau bagaimanapun, The New York Times melaporkan pada Rabu, memetik pegawai tentera Amerika, bahawa siasatan yang sedang dijalankan telah mendapati AS secara awal bertanggungjawab untuk serangan maut di Minab. Penyiasat percaya bahawa Markas Pusat AS bergantung pada data penyasaran yang telah lapuk daripada Agensi Perisikan Pertahanan yang masih mengklasifikasikan bangunan sekolah itu sebagai sebahagian daripada kompaun tentera, walaupun ia telah ditukar menjadi institusi pendidikan lebih daripada satu dekad yang lalu, kata sumber.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More

Semakin keras anda bekerja, semakin teruk keadaan anda—seorang CEO membunyikan amaran mengenai ‘competence hangover’ yang melanda pekerja berprestasi tinggi

March 13, 2026
(SeaPRwire) - Jika anda selalu pertama untuk menawarkan bantuan dan terakhir untuk meninggalkan, anda mungkin sedang menghadapi "hangover keupayaan". Itu sekurang-kurangnya menurut Peter Duris, CEO dan pengasas bersama platform karier Kickresume, yang membunyikan alarm tentang keletihan yang terjadi apabila anda begitu baik dalam pekerjaan anda sehingga semua orang bergantung kepada anda untuk segala-galanya."Berkahaya memastikan segala-galanya dilakukan dengan standard yang tinggi, tetapi ia juga boleh memberi kesan sepanjang masa, membawa kepada tekanan yang tidak perlu," Duris mengingatkan. "Jika anda sering melampaui keperluan kerja, ia boleh menyebabkan hangover keupayaan - sejenis keletihan yang anda boleh dapat apabila anda merasa bertanggungjawab secara semula jadi untuk mengekalkan keadaan."Dalam erti kata lain, semakin baik anda dalam pekerjaan anda, semakin sukar untuk berhenti melakukan kerja itu.Duris tahu: platformnya telah membantu lebih daripada 8 juta orang mendapat pekerjaan di syarikat termasuk Google, Apple, dan Microsoft, memberikan beliau tempat duduk terdepan untuk melihat tabiat dan masalah pekerja yang berjaya di seluruh dunia. Dan data yang beliau perolehi menggambarkan gambaran yang membimbangkan.Penyelidikan sendiri Kickresume mendapati bahawa 48% orang Amerika mengalami sindrom penipuan diri dan bekerja lebih kerana itu. Satu pertiga merasa bersalah apabila mengambil cuti. Hampir satu dalam lima merasa terpaksa terus bekerja walaupun sedang sakit.Tekanan itu bukan sahaja datang dari dalam fikiran anda. Dalam pasaran pekerjaan yang lebih keras di mana pangkat naik terhenti dan AI secara senyap mengancam seluruh kategori pekerjaan pekerja putih, ramai pekerja yang berjaya merasa mereka tidak mempunyai pilihan selain daripada memberikan lebih untuk terus selamat."Jika ini kelihatan seperti anda, ia berbaloi untuk mundur dan mengurangkan beban mental anda," tambah Duris.Mengapa melampaui keperluan kerja memberi kesan yang bertentanganPerangkap itu mudah untuk terjebak. Anda menawarkan untuk mengambil alih projek rakan sekerja, tinggal lewat untuk menyelesaikan masalah yang tidak dapat diselesaikan orang lain, atau berkata ya kepada satu tugas lagi kerana anda tahu anda adalah satu-satunya yang akan melakukannya dengan betul. Anda mengambil sedikit lebih, kemudian lagi sedikit, dan sebelum anda sedar, anda telah secara senyap mengambil lebih daripada bahagian yang sepatutnya.Kickresume menyebut ini sebagai "berfungsi secara berlebihan" - dan mengatakan bahawa ia pada mulanya didorong oleh ketakutan bahawa kerja anda tidak cukup baik.Tetapi akhirnya, ketakutan itu menjadi kebiasaan. Pekerja yang berjaya yang selalu melampaui keperluan kerja mula merasa seolah-olah semua tanggungjawab terletak di bahu mereka sendiri. Pada ketika itu, mundur tidak hanya terasa tidak selesa; ia mula terasa benar-benar mustahil."Menjadi orang yang semua orang bergantung kepada boleh menjadi sangat meletup dan membawa kepada keletihan," Duris mengamati. "Ingat bahawa adalah baik untuk berkata tidak apabila beban kerja anda terlalu berat."Ironinya ialah apa yang kelihatan seperti dedikasi di permukaan boleh secara senyap merosakkan prestasi - dan kesannya memberi kesan kepada kedua-dua pekerja dan majikan dengan kuat. Penyelidikan yang berasingan telah menunjukkan bahawa separuh daripada pekerja berada pada titik putus sekarang. Dan keletihan dan kegagalan yang meluas adalah menyebabkan hilangnya produktiviti sebanyak anggaran $438 bilion setiap tahun.Bagaimana untuk memutuskan kitaran dan mengelakkan keletihanLangkah pertama, kata Duris, ialah menangani kesempurnaan yang mungkin telah membawa anda ke situ pada mulanya."Adalah penting untuk memahami bahawa anda tidak perlu menjadi sempurna dalam kerja atau kehidupan," katanya. "Dan bahawa melampaui keperluan kerja adalah bonus, bukan syarat 100% setiap masa."Menyediakan diri untuk melakukan cukup, bukannya segala-galanya, adalah lebih sukar daripada yang kelihatan untuk orang yang selalu mencapai lebih daripada yang diharapkan. Tetapi jika anda tidak boleh berbuat itu, tiada yang lain akan bertahan.Seterusnya ialah kebiasaan yang lebih sukar untuk diputuskan: berkata ya secara automatik. "Membantu orang lain adalah hebat, tetapi ia juga boleh meningkatkan beban kerja anda jika anda mengambil terlalu banyak," kata Duris. "Bukannya mengambil tugas tanpa sebarang soalan, anda boleh cuba mengatakan bahawa anda mungkin boleh membantu selepas menyelesaikan tugas keutamaan. Ini kemudiannya tidak akan membuat anda terlekat dengan mengambil lebih kerja." Ia adalah perubahan bahasa kecil - tetapi ia memberi ruang untuk anda menilai apa yang anda boleh tanggung sebelum anda telah bersetuju.Dan jika keletihan, dendam yang semakin meningkat, dan perasaan bahawa anda benar-benar tidak boleh berhenti telah mula berlaku, Duris terus terang tentang apa yang perlu berlaku seterusnya. "Jika anda merasakan gejala keletihan dan hangover keupayaan, mungkin sudah masanya untuk mundur," beliau mengingatkan."Anda boleh cuba mengurangkan sebarang waktu lembur yang anda lakukan untuk membantu meningkatkan keseimbangan hidup dan bekerja anda dan tumpukan kepada keutamaan utama anda." Mengurangkan jam lembur bukan tanda malas - ia adalah satu-satunya jalan yang realistik untuk kembali kepada beban kerja yang boleh diteruskan.Menjadi orang terbaik di pejabat dan menjadi orang yang paling keletihan tidak perlu berjalan bersama. Kadang-kadang langkah yang paling bijak ialah mengetahui bila untuk berhenti.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
uSMART HK Expands to 12 Physical Service Centres in One Year, Accelerating “Online x Offline” O2O Community Finance Strategy ACN Newswire

uSMART HK Expands to 12 Physical Service Centres in One Year, Accelerating “Online x Offline” O2O Community Finance Strategy

March 13, 2026
HONG KONG, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) – uSmart Securities Limited ("uSMART Securities/the Company") is pleased to announce the official opening of its ninth and tenth physical service centres in Tai Wai and Tuen Mun. Within just one year, uSMART Securities has expanded its Hong Kong service network to 12 physical service centres, surpassing industry benchmarks and actively implementing its "Online x Offline" (O2O) community finance strategy. This expansion solidifies its position as the “No.1 Hong Kong Funded Fintech Brokerage^” and further enhances brand influence.Promoting Accessible Community Financial ServicesThe Tuen Mun branch held a simple yet meaningful opening ceremony today, marking the official commencement of services and a new chapter in the Company's development. Mr. Neo Lee, Executive Director of uSMART Securities, stated: "The opening of the Tai Wai and Tuen Mun branches represent a crucial strategic move in our commitment to local communities and advancing community-oriented services. We focus not only on network coverage but also on connecting with the community, upholding our 'customer-centric' philosophy. By bridging the gap with residents, we are advancing toward our goal of 'seamless coverage across Hong Kong'."(From left to right: Business Development Manager of uSMART Securities, Executive Director of Research Department of uSMART Securities, Executive Director of uSMART Securities, Marketing Director of uSMART Securities and Business Development Director of uSMART Securities)(From left to right: Business Development Manager of uSMART Securities, Executive Director of Research Department of uSMART Securities, Executive Director of uSMART Securities, Marketing Director of uSMART Securities and Business Development Director of uSMART Securities)Comprehensive Coverage Across Hong Kong 18 DistrictsAiming to accelerate the goal of becoming "the Fintech brokerage with the most service centres in Hong Kong," uSMART Securities will open branches in core areas, Kai Tak and Mong Kok in the second quarter. The company is also actively exploring pop-up stores in shopping malls and participating in various exhibition booths. Through multi-channel engagement with customers across different districts, the company aims to refine its regional presence, enabling citizens across all 18 districts to easily access professional and personalized investment and wealth management services, seamlessly integrating financial experiences into daily life.Diversified Investment ProductsAt the opening ceremony, Neo revealed that uSMART Securities has recently obtained a futures trading license and is preparing to launch futures trading services by mid-year. Upon launch, clients will be able to trade futures, including index futures, commodity futures, and currency futures via the uSMART platform. This expansion provides investors with a more comprehensive range of investment products covering long-term, medium-term, and short-term investments, as well as low, medium, and high expected returns, catering to diverse client needs.Futures services will be fully integrated into the existing uSMART APP trading platform, allowing clients to trade US and Hong Kong stocks, futures, ETFs, funds, and discretionary investment products from a single APP. This enables diversified asset allocation, risk management, and wealth enhancement services, allowing clients to utilize capital efficiently and manage investment portfolios flexibly, truly achieving "one-stop wealth management with comprehensive asset allocation."Promoting Investment Education and Enhancing Client InteractionuSMART Securities is also committed to advancing investor education, regularly hosting various online and offline investment seminars and thematic events such as wine tastings and cocktail workshops. These initiatives deepen client engagement and relationships, enhancing customer retention and loyalty.Meanwhile, a new financial channel led by stock commentator and Executive Director of Research, Mr. Dickie Wong, will officially launch next Monday (March 16). Before the market opens and midday close on every Hong Kong stock trading day, a professional team will provide you with real-time analysis of market dynamics and investment opportunity. uSMART Securities aims to foster closer interaction, helping clients refine their practical skills, optimize investment decisions, and build a more comprehensive platform for learning and practice.Expanding Team SizeIn line with rapid business growth, uSMART Securities is actively advancing local talent recruitment and training. The company expects to increase its workforce by 30% over the next two years across areas including branch operations, product design, wealth management, compliance and risk control, and marketing operations. This expansion aims to enhance team scale and professional capabilities, driving steady business growth.Looking ahead, uSMART Securities will continue to optimize trading experiences and strengthen synergies between offline service points and community activities, further solidifying its leading position in financial technology. By combining innovative technology with community networks, the company strives to provide more convenient and personalized wealth management services for investors of all ages and experience levels, promoting the popularization and intelligent development of Hong Kong's financial ecosystem.^”No.1 Hong Kong Funded Fintech Brokerage" is based on TradeGo Cloud data, with uSMART Securities ranking first in monthly transaction volume among local Hong Kong-funded internet brokers for over a year as of February 2026.About uSMART:uSMART Securities is a leading Hong Kong Funded Fintech Brokerage founded in 2018. Over the past eight years, it has pioneered the fusion of technology and finance, offering stocks trading, asset management, and wealth management solutions. Its proprietary platforms, uSMART HK APP and uSMART SG APP, operated by uSMART Securities (Hong Kong) and uSMART Securities (Singapore) respectively. It supports investments in Hong Kong stocks, US stocks, A-shares (via Shanghai and Shenzhen Stock Connect), Singapore Stocks, Japan Stocks, UK Stocks, US options, ETFs, Funds, Bonds, Asset Management, Structured Notes, Futures, Crypto, Precious Metals, Gold, and forex. Furthermore, uSMART is equipped with a highly professional research and asset management team that offers asset management, wealth management, securities brokerage, institutional business, LPF services, and investment banking, dedicated to serving ultra-high-net-worth individuals and families, corporations, investment institutions, fund companies, and other brokerage firms with comprehensive asset management solutions.For details please visit: https://hk.usmartglobal.comFor any media queries, please contact:Carrie Wong9788 4665carriewong@usmart.hk Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo ACN Newswire

CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream (Lumirix(R)) Achieves Initial Prescriptions in Multiple Regions in China for Patients with Vitiligo

March 13, 2026
SHENZHEN, CHINA, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - On 12 March 2026, China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health, which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) has its innovative prescription medicine ruxolitinib phosphate cream (Lumirix®) (the “Product”, marketed as Opzelura® in the U.S., Europe and Canada) recorded the initial prescriptions for vitiligo patients across 30 provincial-level regions. The prescriptions cover approximately a thousand influential public and private medical institutions in the field of skin health and disease management, including Huashan Hospital, Fudan University, Shanghai Skin Disease Hospital, Dermatology Hospital of Southern Medical University, Second People's Hospital of Chengdu, The First Bethune Hospital of Jilin University, The Second Xiangya Hospital of Central South University, United Family Healthcare Group, among others*. Meanwhile, the Product has become concurrently accessible via over 1,300 offline drugstores as well as JD.com e-commerce platform. *Hospital rankings are listed in no particular order.As the first topical JAK inhibitor approved in China for the treatment of vitiligo, ruxolitinib phosphate cream has officially launched its large-scale clinical application today, marking a breakthrough in China’s vitiligo treatment landscape and ushering in a new era of precision targeted therapy for vitiligo. Supported by safety and efficacy fully demonstrated in clinical studies, the Product is expected to bring new hope for repigmentation to millions of vitiligo patients.The rapid commercialization progress of ruxolitinib phosphate cream underscores strong product operation capabilities of CMS (including Dermavon), while also reflecting the robust supports from China’s regulatory reforms in accelerating patient access to clinically urgently needed innovative drugs. Benefiting from the integrated healthcare ecosystem of the Hainan Free Trade Port and the “Urgently Needed Imported Drugs for Clinical Use” policy, the Product initiated pilot clinical use in August 2023 at Boao Super Hospital within the Boao Lecheng International Medical Tourism Pilot Zone. Pilot usage subsequently expanded to designated medical institutions across the Guangdong–Hong Kong–Macao Greater Bay Area, Beijing-Tianjin region and other regions. In accordance with the relevant regulations of China’s real-world data application pilot project, as well as supported by the Hainan Provincial Medical Products Administration and the Administration of the Boao Lecheng International Medical Tourism Pilot Zone, the Product has accumulated real-world clinical data in China under pilot application, significantly accelerating its clinical, registration and approval timelines. The Product received its Drug Registration Certificate on January 30, 2026 (approval date: January 27, 2026).Following its approval, in less than 1.5 months (including the Chinese New Year holiday), the initial prescriptions for ruxolitinib phosphate cream have been issued across multiple regions and hospitals, reflecting the highly efficient collaboration and concerted efforts among CMS teams, regulatory authorities and business partners. With robust support from the cross-departmental coordination mechanism of the Beijing Daxing Airport Economic Zone Joint Administrative Committee, once import conditions were met, the Product completed customs clearance approval, sampling and related customs procedures within 24 hours, and obtained the drug testing report within 7 working days, representing efficient execution and acceleration for the innovative drugs in China. During this process, the Beijing Municipal Medical Products Administration proactively provided end-to-end policy guidance; the government service center has efficiently completed customs clearance filing; the Beijing Institute for Drug Control has conducted methodological pre-testing to accelerate timelines for innovative drug, and continuous worked during the Chinese Spring Festival; and Daxing Airport Customs provided specialized pre-guidance on declaration and swiftly completed customs review and release. Through parallel workflows and coordinated execution, all parties collectively pressed the “fast-forward button” for the Product’s commercialization, helping this urgently needed innovative therapy reach patients faster.As the Product enters the large-scale clinical application stage, it is expected to further strengthen Dermavon’s comprehensive dermatology solutions and brand value. Building on its leadership in skin health, Dermavon will continue to improve accessibility of ruxolitinib phosphate cream to benefit more vitiligo patients and steadfastly safeguard public skin health through innovation.About VitiligoVitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. The discolored areas usually get bigger with time and the condition could influence skin on any part of the patients’ body. Vitiligo usually affects the appearance of patients, especially on exposed areas such as the face and neck. According to a study that involved over 1,000 diagnosed vitiligo patients, over 45% of patients have facial involvement, and over 20% of patients have neck involvement[1].The obvious presence of white patches may make patients feel that their appearance has been compromised, which in turn materially affects their social life, and is associated with a significantly higher incidence of mental health disorders; accordingly, there is an urgent need for effective treatment options for vitiligo[2].It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[1]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. Ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance.More Information About Ruxolitinib Phosphate CreamRuxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is the first and only drug approved for the repigmentation of non-segmental vitiligo by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA)[3,4]. In the U.S., the Product is indicated for the topical treatment of nonsegmental vitiligo in adult and pediatric patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis (AD) in non-immunocompromised adult and pediatric patients aged 2 years and older whose disease is not well controlled with topical prescription therapies, or when those therapies are not advisable. In Europe, ruxolitinib phosphate cream is approved for the topical treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age. In China, besides vitiligo indication, the product’s NDA for the treatment of mild-to-moderate AD in adults and pediatric patients aged 2 years and older is also under regulatory review, which has been included in the Priority Review List and is expected to accelerate the Product’s AD review process for marketing approval.The Group, through the subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside of Mainland China to the Group (excluding Dermavon and its subsidiary).Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream (excluding territories in which exclusive rights have already been licensed), marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference:1. China Insights Consultancy’s industrial report 2. Wang G, Qiu D, Yang H, Liu W. The prevalence and odds of depression in patients with vitiligo: a meta-analysis[J]. Journal of the European Academy of Dermatology and Venereology, 2018,32(8):1343-1351. DOI:10.1111/jdv.14739. 3. The U.S. FDA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-us-fda-approval-opzeluratm-ruxolitinib-cream4. The EMA approval information can be found on the Incyte official website, as follows:https://investor.incyte.com/news-releases/news-release-details/incyte-announces-european-commission-approval-opzelurarCMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Guoquan Achieves Simultaneous Growth in Scale and Profitability, Core Operating Profit Increases by 48.2% in 2025 ACN Newswire

Guoquan Achieves Simultaneous Growth in Scale and Profitability, Core Operating Profit Increases by 48.2% in 2025

March 13, 2026
HONG KONG, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) – 12 March 2026, Guoquan Food (Shanghai) Co., Ltd. ("Guoquan" or the "Company"; stock code: 2517.HK), a leading one-stop home meal products brand in China, announced its annual results for the year ended 31 December 2025, which have been reviewed by the Audit Committee of the Board.Adhering to the strategic positioning of "community central kitchen" in 2025, the Company successfully established a holistic instant retail store network through a multi-channel, multi-scenario omni-channel layout and the deep integration of online and offline operating models. The Company continuously delved into consumers' demand, developed and iterated a diverse suite of product portfolios, deepened refined store operation and management, and strengthened the construction of a membership ecosystem, effectively enhancing store operational efficiency and market competitiveness. Concurrently, the Company continued to deepen its industrial layout and promote the integrated closed-loop construction of "production, supply and marketing", achieving stable development throughout the year.For the year ended 31 December 2025, the Company's revenue amounted to RMB7,810.0 million, representing a year-on-year increase of 20.7%. Gross profit reached RMB1,686.6 million, a year-on-year increase of 19.0%. Net profit was RMB453.9 million, a significant year-on-year increase of 88.2%. Core operating profit (adjusted for non-recurring items such as gains or losses on fair value changes on unlisted convertible redeemable preferred shares and donations for fire rescue in Tai Po, Hong Kong) was RMB460.7 million, representing a year-on-year increase of 48.2%. Basic and diluted earnings per share were RMB0.1630, a substantial year-on-year increase of 93.8%.Continuously Strengthening Omni-channel Instant Retail: Offline Expansion and Online Engagement Drive GrowthAs of 31 December 2025, the Company's total number of stores nationwide reached 11,566, a net increase of 1,416 stores from 10,150 as at the end of 2024, covering 31 provinces, autonomous regions and municipalities. In terms of regional store layout, the Company achieved a net increase of 1,004 township-level stores in 2025. Addressing the consumption characteristics and needs of township markets, the Company developed differentiated product structures and store displays, accurately aligning with consumer demands in lower-tier markets and further enhancing township market penetration. Concurrently, the Company continued to deploy smart retail scenarios in mid-to-high-tier markets, completing the intelligent and unmanned transformation and upgrade of over 3,000 retail stores in 2025, achieving synergistic development between lower-tier and mid-to-high-tier markets.To empower franchisees, facilitate their sales growth, and further expand consumer reach while offering a more flexible shopping experience, the Company continuously provides support and guidance to franchisees in core areas such as store operations and business development. Leveraging the Company's Guoquan APP, WeChat mini-program, third-party food delivery platforms and social commerce platforms (such as Douyin), a multi-level online sales network has been established. In 2025, the Company achieved over 9.41 billion impressions on platforms through its multi-level Douyin accounts matrix. Stores generated GMV of RMB1.49 billion via the Douyin channel, representing a year-on-year increase of 75.3%.Membership Ecosystem Continuously Improved; Product Portfolio Enhances in Scenarization and RichnessIn 2025, the operation of the Guoquan membership program yielded significant results, further releasing the value of the membership ecosystem. During the Reporting Period, the number of the Company's registered members reached approximately 64.9 million, a year-on-year increase of 57.1%, demonstrating rapid expansion of the membership base. The prepaid card business also achieved stable growth, with the value stored in prepaid cards amounting to approximately RMB1.2 billion during the Reporting Period, a year-on-year increase of 22.3%. This indicates continuously improving member stickiness and consumption contribution, forging a closer connection with consumers.Relying on its substantial membership base, the Company persistently pursues innovation in its product offerings, consistently upholding the business philosophy of providing consumers with "tasty, convenient and value-for-money" products. It continuously enriches its product portfolio and iterates new products to comprehensively meet consumers' diverse dining needs. As of 31 December 2025, the Company had introduced 282 new SKUs of hot pot and barbecue products. It created multiple scenarized meal suites such as the "Barbecue Camping Container Set", "Crayfish Feast Set", and "Six Popular Hot Pot Sets", achieving deep integration of products and consumption scenarios. Furthermore, the Company expanded its product categories within the drinks and beverage consumption scenario, launching products such as NFC fruit juices, craft beer, and flavored tea beverages. This continuously enhances the richness and diversification of the product matrix, further perfecting the one-stop meal products supply system.Deepening Industrial Layout; Strengthening Digitalized Supply Chain ControlGuoquan continues to promote the integrated closed-loop construction of "production, supply and marketing". Adopting a "one-product-one-factory" strategy, it further deepens the breadth and depth of its industrial layout, providing solid production capacity support for business development. As of 31 December 2025, the Company possessed seven food ingredient production plants, covering core categories such as condiments, meatballs, paste and aquatic products, and beef products, forming a comprehensive and well-defined production capacity matrix. Concurrently, the construction of the Company's food production base in Danzhou, Hainan Province, officially commenced. This base will further expand its geographical coverage, optimize the supply chain's radiation radius, and strengthen the national production capacity layout and logistics reach.This solid industrial foundation continuously improves the operational efficiency of the digitalized supply chain. Based on the supply chain system operating from factory to central warehouse and to retail stores, the Company can monitor supply and demand dynamics from the procurement end to the store end, and closely manage inventory levels, thereby achieving efficient management of the entire supply chain. As of 31 December 2025, the Company had deployed 20 digitalized central warehouses across China, achieving swift product circulation through digital stock and barcode management. Simultaneously, the digitalization of the supply chain covering core segments such as production, procurement, warehousing, and logistics allows for precise monitoring of supply-demand dynamics and inventory levels, ensuring the timely supply of products to stores in the Chinese mainland. This comprehensively enhances the overall operational efficiency of the supply chain, solidifying core barriers in cost control and quality assurance.Six Core Strategic Directions: Continuously Advancing Business UpgradesIn 2026, Guoquan targets that the total number of stores will exceed 14,500, representing a net increase of over 2,934 stores, with an estimated store closure rate of less than 4%. It targets high-single-digit growth in store efficiency, and the number of registered members is targeted to exceed 95 million. The Company targets that the growth rate of core operating profit will be significantly higher than that of its revenue.First, Fully expand the sales network with four stores jointly advancing with concerted efforts. Guoquan will continue to build a multi-level sales network, accelerate the expansion of large stores in townships, practice the philosophy of "food equality", and precisely meet the consumption needs of residents in county and township markets. Concurrently, it will explore innovative store formats and upgrade the franchisee management system to build a symbiotic and mutually beneficial franchise ecosystem.Second, Deepen the strategy of community central kitchen to expand community consumption scenarios. The Company will focus on creating food retail solutions for "four meals a day", continuously diversifying its product categories and building a more competitive product matrix to achieve organic sales growth while further consolidating its advantages in lower-tier market layout.Third, Deepen membership operation and IP to advance the community brand project. The Company will continue to advance refined membership operation, deeply integrate media resources such as popular TV commercials, offline community advertising and social media and e-commerce platforms (such as Douyin) to expand its membership base, and improve the membership rights system to enhance member loyalty and stickiness. Furthermore, it will further deepen the operation of its brand IP image "Guobao" to strengthen brand value and emotional resonance with consumers.Fourth, AI big data empower stores to innovate smart retail scenarios. By integrating Internet of Things, big data, and AI technology, the Company will drive the smart operation of stores with data. It will promote the in-depth integration of the Guoquan stir-fry business format with smart cooking machines, accurately analyze consumers' dining habits, optimize dish parameters and cooking procedures for smart cooking machines, realize the standardized production of stir-fry dishes, and optimize the consumer experience.Fifth, Continue to promote the industrial layout and strengthen the advantage of one-product-one-factory. Adhering to the "one-product-one-factory" strategy, Guoquan will further integrate upstream resources domestically and internationally, accelerate the construction of the food production base in Danzhou, Hainan Province, increase R&D investment, and launch more product portfolios with a high quality-price ratio.Sixth, Develop overseas markets in phases to deliver the good taste of China. Guoquan plans to explore and establish a presence in overseas regional markets in a phased manner to unlock long-term growth potential. Leveraging its core competitiveness, it will steadily advance its overseas market exploration. It also plans to take the lead in opening stores in Hong Kong Special Administrative Region, China to accumulate and gather operational experience, gradually achieving overseas product sales and enhancing global brand visibility.About Guoquan Food (Shanghai) CO., LTD. (2517.HK):Guoquan Food (Shanghai) Co., Ltd. (“Guoquan”; Stock Code: 2517.HK) is the leading one-stop home meal products brand in China, offering a variety of ready-to-eat, ready-to-heat, ready-to-cook and prepared ingredients, with a focus on at-home hotpot and barbecue products. Leveraging Company’s robust supply chain capabilities, a strategic industrial layout with self-owned factories, a nationwide network of around 10,000 instant retail stores, and a carefully curated product portfolio, Company offer a variety of home meal products solution under the “Guoquan Shihui” brand, catering to different dining scenarios.This press release is issued by EverBloom (HK) Communications Consultants Group Limited on behalf of Guoquan Food (Shanghai) Co., Ltd. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Mitsubishi Shipbuilding Completes Handover of WAKASHIO MARU Training Ship for National Institute of Technology, Toyama College JCN Newswire

Mitsubishi Shipbuilding Completes Handover of WAKASHIO MARU Training Ship for National Institute of Technology, Toyama College

March 12, 2026
WAKASHIO MARUTOKYO, Mar 13, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Shipbuilding Co., Ltd., a part of Mitsubishi Heavy Industries (MHI) Group, today completed the handover of WAKASHIO MARU, a training ship for National Institute of Technology, Toyama College (NIT, Toyama College). The handover followed a christening and launch ceremony for the ship in October 2025 at the Enoura Plant of MHI's Shimonoseki Shipyard & Machinery Works in Yamaguchi Prefecture, and the completion of interior work and sea trials.This is the fifth generation training ship for NIT, Toyama College, and the first replacement ship for the school in 31 years since 1995. It is the first ship Mitsubishi Shipbuilding has built for the school. The ship will be utilized for navigation practice, operations, and ocean-related research, along with various other educational and community contribution activities to develop marine sector human resources, contribute to local communities, and disseminate maritime-related messages. The ship is also equipped to provide a range of disaster support functions, including transporting relief supplies and providing housing facilities in the event of a natural disaster.Going forward, Mitsubishi Shipbuilding will continue to support its customers and the advancement of society by leveraging its synergy with MHI Group to build ships that embody even more advanced development and design for the maritime field, and contribute to the training of next-generation maritime officers, and oceanographic surveys.Main Specifications of the WAKASHIO MARUOwnerNational Institute of Technology, Toyama College(NIT, Toyama College)LOA56.48 metersBeam10.60 metersDepth5.95 metersGross tonnage389 tonnesCapacityApprox. 60 personsService speed12.5 knotsAbout MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Mitsubishi Heavy Industries to Introduce 10MW-Class Centrifugal Chiller for Next-Generation AI Data Centers in North America JCN Newswire

Mitsubishi Heavy Industries to Introduce 10MW-Class Centrifugal Chiller for Next-Generation AI Data Centers in North America

March 12, 2026
TOKYO, Mar 13, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) today announced its strategic intent to work toward the introduction of a 10-megawatt (MW) class centrifugal chiller for next-generation AI data centers in the North American market, targeting industrial-grade AI computing infrastructure. The company plans to obtain U.S. safety and regulatory certification, including UL, potentially as early as 2026, with commercial availability targeted thereafter.As demand for large-scale AI computing accelerates globally, data center operators are increasingly prioritizing proven reliability, energy efficiency, and water sustainability over experimental technologies. Leveraging decades of industrial experience, MHI is positioning its centrifugal chiller solution as a potential standardized cooling platform for gigawatt-class AI data centers, where operational track record is a critical decision factor.Proven Industrial Leadership Delivering Outstanding Energy and Water EfficiencyMHI's centrifugal chillers are backed by an extensive track record across industrial and mission-critical applications, supported by a leading approximately 60% domestic market share in Japan(*1). This proven performance base provides a strong foundation for data center operators seeking dependable cooling infrastructure for continuous, high load operation.Key features of the solution include:High efficiency centrifugal chiller design utilizing an in-house developed compressor, optimized through a single-compressor configuration to achieve superior part-load and full-load performance.Integrated plant-level control using MHI's proprietary Control System and self-designed Modular Chiller Plant (MCP) architecture, enabling effective utilization of free-cooling operation modes and improved Power Usage Effectiveness (PUE).Low-water-consumption cooling configurations using dry coolers to address growing concerns around water scarcity and Water Usage Effectiveness (WUE) in large-scale data centers.A system design philosophy that emphasizes operational stability, repeatability, and long-term efficiency, rather than reliance on unproven technologies.Together, these features are expected to facilitate both energy efficiency and environmental sustainability, while maintaining the robustness required for AI workloads operating at unprecedented scale.Designed for Emerging AI Data Center ArchitecturesThe newly announced 10MW-class chiller is optimally designed with the objective of aligning with emerging reference architectures for large-scale AI computing facilities, which demand higher cooling capacity, increased redundancy, and standardized deployment models.By addressing the cooling requirements of gigawatt-class AI data centers, MHI's solution aims to support the evolution of data centers from traditional IT facilities into fully integrated AI data centers, where cooling infrastructure plays a direct role in enabling computing performance, uptime, and total cost optimization.Mitsubishi Heavy Industries Group is dedicated to delivering more sustainable and reliable solutions to data centers by combining decarbonized power generation, reliable power distribution, high efficiency cooling systems and Integrated Digital Solutions. We seek to empower our customers through the complete lifecycle from design phase to post deployment with actionable insights, solutions and services. This initiative represents a key step in MHI's broader global strategy to expand its data center cooling portfolio, with a strong focus on high-density AI workloads, sustainability, and industrial-grade reliability.(*1) This represents MHI Group's share of the centrifugal chiller market in Japan.About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world’s leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More

Revenue Triples in Four Years! Qunabox Group Reports RMB290 Million in Net Profit in 2025

March 12, 2026
HONG KONG, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) – Against the dual boost of a global technological revolution and China’s policies to expand domestic demand, the integration of AI with consumption scenarios has entered a phase of accelerated development. As a leading enterprise in China’s AI interactive marketing services sector, Qunabox Group (00917.HK) has seized industry opportunities and continued to deepen its core strategy of “AI + Consumption Scenarios”. The Company has achieved breakthroughs across multiple dimensions, including technological research and development, business deployment and global expansion, demonstrating strong development resilience and growth potential.On 12 March, Qunabox Group announced its 2025 financial results. According to the data, the Company maintained a robust growth momentum during the year, recording revenue of RMB1.663 billion, a year-on-year increase of 24.2%. More notably, the Company’s profitability continued to strengthen, with profit for the period reaching RMB290 million. The Company successfully turned losses into profits, marking the beginning of a new stage of development.The accounting loss recorded by Qunabox Group in 2024 was mainly attributable to changes in the fair value of preferred shares during the listing period. With the elimination of these accounting-related disturbances, the Company’s genuine intrinsic profitability has become increasingly evident, signaling that Qunabox has officially entered a golden period of growth driven by the explosive release of scale effects.Building a Solid Technological Foundation and Driving Qualitative Performance Growth Through Product InnovationIn 2025, Qunabox Group continued to deepen its “AI + Consumption Scenarios” strategy by increasing investment in underlying technologies and platform capabilities. R&D expenses rose significantly by 75% year-on-year, laying a solid technological foundation for the Company’s development. By building a unified AI technology middle platform and a modular capability system, the Group achieved improvements in both R&D efficiency and technology reusability.Its self-developed AI-OMNI multimodal neural integrated collaboration engine achieved key breakthroughs in perception, decision-making, and execution, becoming the core technological support for the Group’s product innovation. Leveraging these technological advantages, Qunabox Group systematically launched and upgraded a series of AI-powered interactive marketing products, including AI digital human shopping assistants, AI holographic marketing cabinets, an AIGC middle platform and resource library, AI Agent workstations, and AI data and strategy analytics solutions. These innovations provide reliable support for implementation across multiple businesses and scenarios, directly driving high-quality revenue growth.Business Synergy Fueling Expansion, Global Layout Unlocking New Growth PotentialBy business segment, the marketing services segment, the Group’s core business, recorded a year-on-year revenue increase of 27.8% in 2025 to reach RMB1.402 billion. Among them, the high-margin value-added marketing services delivered a standout performance, with revenue hitting RMB236 million, a year-on-year surge of 32.9%. Its revenue share continued to rise, driving the optimization of the overall revenue quality and gross margin structure. In 2025, the gross profit of this segment amounted to RMB875 million, up 28.8% year on year.As the strategic practice platform for the Group's "AI experiential consumption" initiative, the merchandise sales segment achieved continuous improvements in the commercial conversion efficiency of AI interactive terminals. This was accomplished through expanding the terminal network in high-potential cities such as Hangzhou, Chengdu and Ningbo, optimizing the product portfolio toward higher-margin items, and replacing traditional price promotions with intelligent interactive marketing. The segment has developed strong synergies with the core marketing services and become an important scenario for the commercial application of cutting-edge technologies. In 2025, revenue from the merchandise sales segment of Qunabox Group increased by 5.2% year on year to RMB194 million, while gross profit rose by 12.7% year on year to RMB49 million.The layout of lifestyle and innovative businesses has unlocked a new dimension of global growth for Qunabox Group. In 2025, focusing on "AI + Lifestyle", the Group expanded into the Middle East, Southeast Asia and Australia simultaneously. An overseas business department was established to oversee the full implementation of global operations, and strategic cooperation has been reached with key local partners in Dubai. Currently, Qunabox Group has completed the preliminary preparations for its AI-powered indoor entertainment spaces and obtained operating licenses in Dubai and Singapore. The establishment of overseas teams, product localization and refinement, as well as the integration of software and hardware systems are advancing steadily. The Group has also completed the validation of localized AI models, ensuring that its AI-driven interactive experiences can be accurately adapted to multilingual and cross-cultural scenarios. This lays a solid foundation for the scalable expansion of its overseas business, which is expected to become the Company’s second growth curve for performance.Expanding Customer Base: A New Journey for AI + Consumption ScenariosLeveraging its innovative and efficient business model and outstanding service capabilities, Qunabox Group has maintained sound and stable partnerships with brand clients. Additionally, the Company has expanded the application scenarios of its services, enriched and optimized its AI-driven interactive marketing products, developed data strategy solutions, and refined its marketing product portfolio and service model. As a result, the Company has continuously expanded its industry influence, deepened cooperation with high-quality clients, and steadily grown its premium client base, with both the number of brand clients and key accounts on the rise. In 2025, the total number of brand clients served by Qunabox Group increased to 332 for the full year, including 58 key accounts. The average revenue per key account grew by 15% year on year, reflecting a continuous rise in client value and further consolidating the foundation for the Company’s sustained performance growth.Supported by strong performance, Qunabox Group maintained a sound financial position and ample cash flow throughout the year. As at 31 December 2025, the Group’s cash and bank balances amounted to RMB1.506 billion, providing strong support for subsequent investments in technology, business expansion and global deployment.In summary, Qunabox Group’s outstanding performance in 2025 is the inevitable result of its years of deep engagement in AI technologies and its steadfast implementation of the “AI + Consumption Scenarios” strategy. The turnaround from loss to profit further demonstrates the sustainability of its business model and the growth potential of its profitability.Looking ahead, as the integration of artificial intelligence with physical consumption scenarios continues to deepen, a window of opportunity has emerged for the large-scale deployment of AI applications. With technology at its core and scenarios as its foundation, Qunabox Group is building a cross-regional, end-to-end AI lifestyle platform. Amid the accelerated cultivation of new quality productive forces, the Company, leveraging its technological barriers, scenario advantages and global vision, is well positioned to continue leading the industry transformation in the integration of AI and consumption and to achieve long-term sustainable development of its own. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Spritzer Sparkling’s ‘Serikan Raya, Sparkling-kan Suasana’ Festive Fusion Message Promotes Togetherness and Tradition with a Light, Modern Twist JCN Newswire

Spritzer Sparkling’s ‘Serikan Raya, Sparkling-kan Suasana’ Festive Fusion Message Promotes Togetherness and Tradition with a Light, Modern Twist

March 12, 2026
From a joyful Raya musical to new and improved festive recipes, Spritzer Sparkling inspires Malaysians to embrace fresh new ideas alongside tradition to elevate their Raya celebrationsSpritzer Sparkling’s 2026 Raya musical brand film “Samting-Samting”, stars Fimie Don and Wani Kayrie as a married couple, and Elliza Razak as Mak Ngah.TAIPING, Malaysia, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - Hari Raya Aidilfitri in the month of Syawal is a cherished time of celebration and time-honoured family traditions, with the kitchen often becoming the heart of the festivities. As families balik kampung and fill their homes with the joy and warmth of festive cooking this year, Spritzer Sparkling invites Malaysians to celebrate Raya with a modern twist through its ‘Serikan Raya, Sparkling-kan Suasana’ campaign, showcasing the versatility of the product in boosting the creativity and flair of beloved Raya dishes.For the first time, Spritzer Sparkling is expanding beyond its well-loved role as a beverage mixer with a fresh take on festive cooking through the multipurpose use of its naturally refreshing sparkling water in your favourite recipes. Spritzer Sparkling transforms five traditional must-have Raya dishes into festive showstoppers, bringing a new dimension of taste with its lively carbonation enhancing the texture, crispiness, and tenderness of the dishes. These favourites include Cucur Udang Crispy, Rendang Tok Melting, and Roti Jala with Kari Ayam, alongside refreshing drinks like Bunga Longan Sparkling and Limau Selasih Pudina Sparkling.This Raya, add a little ‘Samting-Samting’ extra to your recipes for an exciting new twist on your favourite festive dishes with Spritzer SparklingEach recipe showcases how the natural bubbles from Spritzer Sparkling help create lighter, crispier batters for a satisfying crunch and more tender, flavourful meats without changing the essence of the dishes. Whether it is giving your cucur udang a delightful crisp or tenderising your rendang meat and shortening the braising time, Spritzer Sparkling makes these traditional favourites even more enjoyable in simple, effortless ways.Shiao Chan, Head of Marketing at Spritzer, said, “Hari Raya Aidilfitri is a celebration deeply rooted in family traditions where food plays a central role in bringing people together. Through ‘Serikan Raya, Sparkling-kan Suasana’, we wanted to show Malaysians that tradition and heritage can co-exist and even be preserved through innovation and new perspectives. Spritzer Sparkling is not just a refreshing beverage for every season, but also a multi-faceted ingredient that can enhance festive dishes and drinks, creating memorable family moments in the kitchen and around the dining table.”A Musical Aidilfitri AwaitsBringing the Raya story to life is Spritzer’s musical film titled ‘Samting-Samting’, starring Fimie Don, Wani Kayrie and Elliza Razak. As the official Spritzer Sparkling brand ambassadors for Raya 2026, Fimie Don and Wani Kayrie, play a modern newlywed couple returning to the husband’s kampung for their first Raya together in the film that blends comedy, drama and music in an irresistibly Malaysian narrative.The young wife, Alia, takes on the kitchen with confidence, using her own modern approach to classic family dishes, prepared using her secret ingredient: Spritzer Sparkling. Mak Ngah, the family’s long-standing culinary matriarch, feels her role is being challenged and grows increasingly suspicious about Alia’s unusually delicious cooking, suspecting “Samting-Samting” is amiss. The story humorously unravels the “secret” behind Alia’s crowd-pleasing flavours, capturing family dynamics and celebrating new perspectives, shared discovery, and the warmth of intergenerational bonding.Home-cooks excited to try this new twist to classic recipes can check out the recipes for the featured dishes and beverages using Spritzer Sparkling as a game-changing ingredient on Spritzer’s Raya microsite here.Spritzer’s 2026 Raya campaign celebrates family traditions, playful generational dynamics in the kitchen, and creative festive cooking with Spritzer Sparkling.Also available on the website are the musical film, promotional details, meet-and-greet information with Fimie Don and Wani Kayrie, as well as gift-with-purchase promotions available at participating outlets nationwide.About SpritzerEstablished in 1989, Spritzer is a leading Malaysian bottled water brand, sourcing natural mineral water from a protected 430-acre rainforest in Taiping. Naturally filtered through underground rock layers for over 15 years, our water is enriched with essential minerals like Silica, known to support skin, bones, hair, and nails.Combining smart manufacturing with sustainable practices, Spritzer ensures every bottle meets the highest quality and safety standards. Our packaging is 100% recyclable and made from recycled materials, reflecting our commitment to environmental stewardship and a circular economy.Tested annually by SIRIM to be free from microplastics, Spritzer offers consumers trusted, natural hydration. Our diverse product range includes Natural Mineral Water, Original and Flavoured Sparkling Water, Distilled Water, and Fruit-Flavoured Beverages—crafted to suit every lifestyle and occasion.With a clear vision to become a fully circular brand by 2030, Spritzer leads the industry in innovation, quality, and sustainability.Spritzer — where nature, innovation, and sustainability come together in every bottleFor more information, visit www.spritzer.com.myFor media inquiries please contact:Farah ShahrulAssociate Consultant, Narro CommunicationsE: farah@narrocomms.comWinnie ChinHead of Public Relations, Spritzer BhdE: winniecgl@spritzer.com.my Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
Spritzer Sparkling’s ‘Serikan Raya, Sparkling-kan Suasana’ Festive Fusion Message Promotes Togetherness and Tradition with a Light, Modern Twist ACN Newswire

Spritzer Sparkling’s ‘Serikan Raya, Sparkling-kan Suasana’ Festive Fusion Message Promotes Togetherness and Tradition with a Light, Modern Twist

March 12, 2026
From a joyful Raya musical to new and improved festive recipes, Spritzer Sparkling inspires Malaysians to embrace fresh new ideas alongside tradition to elevate their Raya celebrationsSpritzer Sparkling’s 2026 Raya musical brand film “Samting-Samting”, stars Fimie Don and Wani Kayrie as a married couple, and Elliza Razak as Mak Ngah.TAIPING, Malaysia, Mar 13, 2026 - (ACN Newswire via SeaPRwire.com) - Hari Raya Aidilfitri in the month of Syawal is a cherished time of celebration and time-honoured family traditions, with the kitchen often becoming the heart of the festivities. As families balik kampung and fill their homes with the joy and warmth of festive cooking this year, Spritzer Sparkling invites Malaysians to celebrate Raya with a modern twist through its ‘Serikan Raya, Sparkling-kan Suasana’ campaign, showcasing the versatility of the product in boosting the creativity and flair of beloved Raya dishes.For the first time, Spritzer Sparkling is expanding beyond its well-loved role as a beverage mixer with a fresh take on festive cooking through the multipurpose use of its naturally refreshing sparkling water in your favourite recipes. Spritzer Sparkling transforms five traditional must-have Raya dishes into festive showstoppers, bringing a new dimension of taste with its lively carbonation enhancing the texture, crispiness, and tenderness of the dishes. These favourites include Cucur Udang Crispy, Rendang Tok Melting, and Roti Jala with Kari Ayam, alongside refreshing drinks like Bunga Longan Sparkling and Limau Selasih Pudina Sparkling.This Raya, add a little ‘Samting-Samting’ extra to your recipes for an exciting new twist on your favourite festive dishes with Spritzer SparklingEach recipe showcases how the natural bubbles from Spritzer Sparkling help create lighter, crispier batters for a satisfying crunch and more tender, flavourful meats without changing the essence of the dishes. Whether it is giving your cucur udang a delightful crisp or tenderising your rendang meat and shortening the braising time, Spritzer Sparkling makes these traditional favourites even more enjoyable in simple, effortless ways.Shiao Chan, Head of Marketing at Spritzer, said, “Hari Raya Aidilfitri is a celebration deeply rooted in family traditions where food plays a central role in bringing people together. Through ‘Serikan Raya, Sparkling-kan Suasana’, we wanted to show Malaysians that tradition and heritage can co-exist and even be preserved through innovation and new perspectives. Spritzer Sparkling is not just a refreshing beverage for every season, but also a multi-faceted ingredient that can enhance festive dishes and drinks, creating memorable family moments in the kitchen and around the dining table.”A Musical Aidilfitri AwaitsBringing the Raya story to life is Spritzer’s musical film titled ‘Samting-Samting’, starring Fimie Don, Wani Kayrie and Elliza Razak. As the official Spritzer Sparkling brand ambassadors for Raya 2026, Fimie Don and Wani Kayrie, play a modern newlywed couple returning to the husband’s kampung for their first Raya together in the film that blends comedy, drama and music in an irresistibly Malaysian narrative.The young wife, Alia, takes on the kitchen with confidence, using her own modern approach to classic family dishes, prepared using her secret ingredient: Spritzer Sparkling. Mak Ngah, the family’s long-standing culinary matriarch, feels her role is being challenged and grows increasingly suspicious about Alia’s unusually delicious cooking, suspecting “Samting-Samting” is amiss. The story humorously unravels the “secret” behind Alia’s crowd-pleasing flavours, capturing family dynamics and celebrating new perspectives, shared discovery, and the warmth of intergenerational bonding.Home-cooks excited to try this new twist to classic recipes can check out the recipes for the featured dishes and beverages using Spritzer Sparkling as a game-changing ingredient on Spritzer’s Raya microsite here.Spritzer’s 2026 Raya campaign celebrates family traditions, playful generational dynamics in the kitchen, and creative festive cooking with Spritzer Sparkling.Also available on the website are the musical film, promotional details, meet-and-greet information with Fimie Don and Wani Kayrie, as well as gift-with-purchase promotions available at participating outlets nationwide.About SpritzerEstablished in 1989, Spritzer is a leading Malaysian bottled water brand, sourcing natural mineral water from a protected 430-acre rainforest in Taiping. Naturally filtered through underground rock layers for over 15 years, our water is enriched with essential minerals like Silica, known to support skin, bones, hair, and nails.Combining smart manufacturing with sustainable practices, Spritzer ensures every bottle meets the highest quality and safety standards. Our packaging is 100% recyclable and made from recycled materials, reflecting our commitment to environmental stewardship and a circular economy.Tested annually by SIRIM to be free from microplastics, Spritzer offers consumers trusted, natural hydration. Our diverse product range includes Natural Mineral Water, Original and Flavoured Sparkling Water, Distilled Water, and Fruit-Flavoured Beverages—crafted to suit every lifestyle and occasion.With a clear vision to become a fully circular brand by 2030, Spritzer leads the industry in innovation, quality, and sustainability.Spritzer — where nature, innovation, and sustainability come together in every bottleFor more information, visit www.spritzer.com.myFor media inquiries please contact:Farah ShahrulAssociate Consultant, Narro CommunicationsE: farah@narrocomms.comWinnie ChinHead of Public Relations, Spritzer BhdE: winniecgl@spritzer.com.my Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Ripple bernilai $50 bilion selepas pembelian semula saham $750 juta

March 12, 2026
(SeaPRwire) - Ripple, syarikat fintech yang terkenal kerana perkaitannya dengan cryptocurrency XRP, akan membeli balik kira-kira $750 juta saham daripada pelabur dan pekerja, yang akan meletakkan penilaian syarikat itu pada kira-kira $50 bilion. Rancangan ini pertama kali dilaporkan oleh Bloomberg, yang merujuk kepada sumber yang biasa dengan perkara ini. Penilaian Ripple telah meningkat kira-kira 25% sejak November, apabila ia mengumpul $500 juta dalam pusingan pembiayaan yang disokong oleh Citadel Securities dan Fortress Investment Group, antara lain. Penilaiannya yang semakin meningkat menjadikan syarikat ini kisah kejayaan baru-baru yang jarang berlaku dalam industri kripto yang telah merosot sejak penghujung tahun lepas. Bitcoin telah turun kira-kira 44% sejak harga tertinggi sepanjang masa ia iaitu $126,000 pada Oktober, menurut Binance. Ditubuhkan pada tahun 2012, syarikat ini adalah pengguna awal kripto. Ripple kini bertujuan untuk membantu institusi kewangan menghantar wang ke seluruh dunia dengan lebih murah dan cepat daripada pertukaran asing tradisional. Ia melakukan ini melalui XRP Ledger, cryptocurrency yang diciptanya, yang berfungsi sebagai jambatan antara mata wang. Pada tahun 2025, syarikat ini mengembangkan melalui pemerolehan untuk perkhidmatan seperti perdagangan dan infrastruktur stablecoin. Ia membeli brokerage utama Hidden Road dengan harga $1.25 bilion, dan memperoleh syarikat pengurusan kewangan GTreasury dengan harga $1 bilion. Ripple berkata pada awal bulan ini bahawa ia telah memproses lebih daripada $100 bilion dalam transaksi. Seperti cryptocurrency utama lain, XRP telah mengalami penurunan dalam beberapa bulan terakhir. Sejak harga tertinggi sepanjang masa ia pada Julai, cryptocurrency ini telah turun kira-kira 62% kepada harga semasa ia iaitu kira-kira $1.38, menurut Binance. Ripple telah dapat bertahan daripada penurunan ini sebahagiannya kerana ia memiliki rizab besar XRP yang dijual secara berkala, dan kerana firma ini telah membina produk perkhidmatan kewangan lain.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More
IDF menggugurkan pertuduhan terhadap anggota tentera yang dituduh melakukan serangan seksual terhadap tahanan Palestin kewangan

IDF menggugurkan pertuduhan terhadap anggota tentera yang dituduh melakukan serangan seksual terhadap tahanan Palestin

March 12, 2026
(SeaPRwire) - Sebuah kumpulan hak asasi manusia Israel telah memberi amaran bahawa keputusan itu memberi tentera “lesen untuk merogol” tahanan Palestin Tentera Israel telah menggugurkan pertuduhan terhadap tentera yang dituduh melakukan penderaan seksual terhadap seorang tahanan Palestin di kemudahan tahanan masa perang di pangkalan Sde Teiman. Kes berprofil tinggi ini telah membahagikan masyarakat Israel secara mendalam. Insiden itu berkaitan dengan peristiwa pada Julai 2024 di pangkalan tentera di selatan Israel, di mana lima anggota simpanan pada mulanya disiasat kerana merogol dan kemudian didakwa atas “penderaan teruk” selepas video yang bocor kelihatan menunjukkan seorang tahanan Palestin yang ditutup matanya diserang. Israel Defense Forces (IDF) menyatakan pada hari Khamis bahawa pendakwa raya telah menarik balik dakwaan tersebut, dengan alasan bukti yang tidak mencukupi untuk mendapatkan sabitan dan kebimbangan prosedur selepas rakaman video itu dibocorkan kepada media. Pihak tentera juga menyatakan bahawa mangsa yang didakwa telah dihantar pulang ke Gaza, mewujudkan ketidakpastian sama ada dia akan dapat memberi keterangan dalam perbicaraan. Dalam video tersebut, anggota tentera dilihat membawa ke tepi seorang tahanan yang terbaring meniarap dan mengelilinginya dengan perisai rusuhan dalam apa yang kelihatan sebagai percubaan untuk menyembunyikan tindakan mereka. Dakwaan itu menyatakan salah seorang anggota tentera telah menikam tahanan tersebut berhampiran rektum dengan objek tajam. Tahanan itu kemudiannya dibawa ke hospital dalam keadaan yang mengancam nyawa dengan patah tulang rusuk serta trauma tumpul pada dada dan perut. Dia menjalani pembedahan sebelum dikembalikan ke kemudahan itu beberapa hari kemudian. Skandal itu menyumbang kepada peletakan jawatan bekas peguam bela tentera IDF, Mejar Jeneral Yifat Tomer-Yerushalmi, yang mengakui membenarkan pelepasan rakaman tersebut “untuk menangkis propaganda palsu.” Kes itu mencetuskan perdebatan nasional yang sengit. Anggota simpanan yang dituduh telah mempertahankan tindakan mereka secara terbuka, mendakwa mereka didakwa secara tidak adil dan berikrar untuk “berjuang demi keadilan.” Pada hari Khamis, Perdana Menteri Israel Benjamin Netanyahu menyambut baik keputusan itu, dengan menyatakan bahawa “Israel mesti mengejar musuh-musuhnya, bukan pejuang wira-wiranya.” Menteri Pertahanan Israel Katz juga berkata “keadilan telah ditegakkan.” Walau bagaimanapun, kumpulan hak asasi manusia mengkritik keras keputusan itu. Public Committee Against Torture in Israel menuduh IDF cuba menutup skandal tersebut, dengan menyatakan bahawa “peguam bela tentera Israel baru sahaja memberi tenteranya lesen untuk merogol … asalkan mangsanya adalah warga Palestin.” Pangkalan Sde Teiman, yang sebahagiannya ditukar menjadi kem tahanan bagi warga Palestin yang disyaki terlibat dalam aktiviti militan semasa perang Gaza, telah menghadapi dakwaan penyeksaan dan penderaan yang meluas.Artikel ini disediakan oleh pembekal kandungan pihak ketiga. SeaPRwire (https://www.seaprwire.com/) tidak memberi sebarang waranti atau perwakilan berkaitan dengannya. Sektor: Top Story, Berita Harian SeaPRwire menyampaikan edaran siaran akhbar secara masa nyata untuk syarikat dan institusi, mencapai lebih daripada 6,500 kedai media, 86,000 penyunting dan wartawan, dan 3.5 juta desktop profesional di seluruh 90 negara. SeaPRwire menyokong pengedaran siaran akhbar dalam bahasa Inggeris, Korea, Jepun, Arab, Cina Ringkas, Cina Tradisional, Vietnam, Thai, Indonesia, Melayu, Jerman, Rusia, Perancis, Sepanyol, Portugis dan bahasa-bahasa lain.
More